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ABSTRACT
Members of the Neuron-Specific Gene family (NSG1-3) play critical roles in
excitatory synaptic transmission via regulation of AMPA receptor surface
expression within the post-synaptic density (PSD). While NSG1 and NSG3
regulate AMPAR recycling and endocytosis, respectively, the function of NSG2
has remained elusive. Here we undertook a series of studies to assess the role of
NSG2 in excitatory synaptic transmission. We found that a portion of NSG2
punctae localized with HOMER1 and surface AMPARs at excitatory synapses and
that NSG2 AMPAR subunits in mouse brain. Knockout of NSG2 selectively
impaired the frequency of AMPA mEPSCs, while overexpression caused a
significant increase in the amplitude of AMPA mEPSCs. Despite the fact that
NSG2 is actively trafficked, both static and extended timelapse (3 hr) imaging
revealed that NSG2 was stably localized at ~30% of glutamatergic PSDs.
Interestingly, this subset appeared largely non-overlapping with NSG1.
Furthermore, endogenous NSG2 was associated with greater AMPAR surface
expression that appeared to be independent of neuronal activity. Together, these
data reveal that NSG2 is an AMPAR-binding protein that is required for normal
synapse formation and/or maintenance. In addition, they suggest a novel type of
postsynaptic diversity via selective incorporation of NSG1 and NSG2.
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Chapter 1: Introduction
The excitatory synapse and synaptic neurotransmission
The mammalian brain consists of billions of neurons that form precise
functional connections with each other at specialized junctions called synapses to
give rise to a functional network. Synapses are fundamental units of
neurotransmission where presynaptic axons contact postsynaptic dendrites.
Glutamate is one of the most prevalent neurotransmitter in the brain and mediates
excitatory neurotransmission (Micheva et al., 2010). Presynaptic glutamate is
released as a culminating event of an action potential and diffuses across the
synaptic cleft and acts on excitatory postsynaptic glutamate receptors. These are
primarily the AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)
receptors (AMPARs) and NMDA (N-methyl-D-aspartic acid) receptors (NMDARs).
Glutamate binding allows for an influx of Na+ ions (AMPAR) and Na+ and Ca2+
(NMDAR) into the postsynaptic neuron causing an electrical depolarization and
thereby, propagation of excitatory synaptic transmission. This transmission is
thought to occur specifically within the postsynaptic density (PSD). The ~100nm of
membrane immediately adjacent to the PSD is called the perisynaptic region and
differs considerably in molecular composition from the more distal extrasynaptic
membrane and contains ‘endocytic zones’ which have proteins like clathrin and
AP2 (Rácz et al., 2004).
A critical and intriguing property of neuronal synapses is ability to undergo
‘synaptic plasticity’, long-lasting changes in the strength of a synapse in response
to altered neuronal activity. It is widely accepted that these changes allow for
information storage in response to experience and is the basis for learning and
memory (Malenka and Bear, 2004). In the long term, information storage is also
facilitated by the plasticity of the functional neural networks which lends itself to
modifications by addition of new and/or removal of existing synapses (Yuste and
Bonhoeffer, 2001; Chklovskii et al., 2004). It can therefore be appreciated that the
fidelity of synaptogenesis is critical for every conceivable function we carry out on
a daily basis. Synaptogenesis involves the correct localization of both pre- and
postsynaptic proteins. Improper synaptic development or function are major
1

contributors

to

pathological

states

such

as

various

neuropsychiatric

(schizophrenia), neurodevelopmental (autism) and neurodegenerative conditions
(Alzheimer's

disease)

(Javitt,

2004).

Therefore,

recognizing the molecular underpinnings of synaptic activity and plasticity is of
fundamental biological and clinical relevance.

The AMPA Receptors (AMPARs)
The postsynaptic AMPARs are critical mediators of the vast majority of fast
excitatory synaptic transmission in the mammalian brain. Further, synaptic
strength at glutamatergic synapses is largely determined by the number,
composition,

and

posttranslational

modifications

(PTM)

of

AMPARs

in

the postsynaptic membrane (Malinow and Malenka, 2002; Huganir and Nicoll,
2013). At their most fundamental, AMPARs ligand-gated ion channels that only
require the presence of glutamate within their binding domain to gate open
(Shepherd and Huganir, 2007). In addition, they are non-specific ion channels
which primarily conduct sodium (Na+) and potassium (K+) down their
electrochemical gradients. In most cases, glutamatergic transmission causes
AMPAR gating, causing depolarization via Na+ influx. Only in very specific cases
are AMPARs permeable to Ca2+, and can therefore, trigger downstream signaling
cascades (Shepherd and Huganir, 2007), but we will not discuss this here as it is
of unknown relevance to the current work.
The numbers and the types of AMPARs present at synapses determine the
degree of synaptic plasticity at that synapse. For example, during strengthening,
synapses are potentiated by addition of AMPARs and during weakening, AMPAR
at the synapse are removed by endocytosis. AMPARs are comprised of four
subunits (GluA1 through GluA4) that associate into hetero-tetramers. Each
tetramer is made of two homomeric dimers to give rise to various combinations of
postsynaptic AMPARs. The particular type at a synapse governs the protein
trafficking and ionic conductivity characteristics (Shepherd and Huganir, 2007).
While GluA1–GluA3 are the most commonly expressed subunits throughout the
nervous system, GluA4 expression is more abundant during early development
2

(Zhu et al., 2000). In the hippocampal CA1 neurons, the majority of AMPARs are
made up of GluA1/GluA2 and GluA2/GluA3 tetramers (Wenthold et al., 1996).
Previous studies of AMPAR subunit expression levels suggest that subunit
combinations are relatively similar across various brain regions (Lu et al., 2009;
Schwenk et al., 2014).

How could AMPARs mediate information storage in the brain?
The stoichiometry of AMPAR at a synapse, their association and
interactions with other proteins and PTMs allows for a range of probabilities for
information coding. This could be the molecular basis for AMPAR dependent
synaptic plasticity during learning and memory. AMPARs turnover at the synaptic
surface involves three modes of highly regulated protein trafficking events. The
first two modes are AMPAR endocytosis and exocytosis which may be
homeostatic or activity dependent. The third mode involves exocytosis of AMPAR
at an extrasynaptic site followed by lateral diffusion in the plasma membrane.
Diffusing AMPARs at the synapse are trapped at the postsynaptic density (PSD)
(Malinow and Malenka, 2002; Huganir and Nicoll, 2013). AMPARs surface levels
are also regulated by a range of PTMs such as ubiquitination, phosphorylation and
palmitoylation. PTMs and an array of protein-protein interactions during cellular
signaling events further funnel in to regulate AMPAR synaptic trafficking and
anchoring, and ion conductance properties (Lu and Roche, 2012; Huganir and
Nicoll, 2013). Together AMPARs are highly dynamic and their synaptic levels
which in turn is governed by receptor subunit composition (channel conductance),
protein interaction and trafficking and PTMs regulate the balance between synaptic
accumulation and removal. While the vast amount of information regarding specific
AMPAR trafficking mechanisms is too large to cover here, a number of excellent
review articles are available (Anggono and Huganir, 2012; Huganir and Nicoll,
2013; Diering and Huganir, 2018). Here I will lay a general foundation for
understanding AMPAR trafficking with a focus on the specific mechanisms
pertinent to NSG family members.
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Synaptic Plasticity
Synaptic plasticity is widely accepted to be the molecular and cellular
correlate of learning and memory. Plasticity involves a change in the equilibrium
that regulates synaptic AMPAR accumulation or removal. This experience
dependent potentiation or depression of synaptic strength tunes neural circuits and
enables coding for learned memories and behaviors (Mayford et al., 2012;
Takeuchi et al., 2014). Regulated endocytosis of synaptic AMPAR leading to
reduced synaptic strength corresponds to the molecular process of long-term
depression (LTD). The opposite effect of regulated exocytosis of AMPARs leads
to increased synaptic AMPARs which correlates with increases in synaptic
strength. This molecular process is known as long-term potentiation (LTP) (Bredt
and Nicoll, 2003; Henley and Wilkinson, 2013). Additionally synapses can also get
scaled during homeostatic plasticity. This process involves a cell wide or global
network wide adjustment of synaptic AMPARs levels to maintain a homeostatic
output from particular neurons during variable levels of neuronal circuit activity
(Fernandes and Carvalho, 2016).

AMPARs in LTP: One of the best characterized and major form of synaptic
strengthening is the NMDAR dependent LTP. This Ca2+ dependent process results
in heightened AMPAR numbers in the postsynaptic membrane (Huganir and Nicoll,
2013). Pre-synaptic activity is coupled to Ca2+ influx through the NMDARs leading
to a local increase in synaptic Ca2+. Calcium dependent downstream signaling via
Ca2+/Calmodulin dependent protein kinases (CaMKII) eventually leads to
phosphorylation of various GluA subunits via PKA. However, phosphorylation of
GluA1 appears to be the most critical in promoting AMPAR targeting to the
postsynaptic membrane (Barria et al., 1997; Kristensen et al., 2011). Extrasynaptic
AMPAR diffusing locally in the plasma membrane near the synapse also appear
to supply the increased demand for AMPAR during LTP. This non synaptic AMPAR
is replenished by homeostatic exocytosis from an intracellular reservoir of
AMPARs in recycling endosomes (Anggono and Huganir, 2012; Huganir and
Nicoll, 2013). AMPAR subunit GluA1’s interaction with the scaffold protein 4.1N
4

via its C-termini promotes its exocytosis from endosomal receptor pools (Lin et al.,
2009). In addition to GluA1, AMPAR subunits GluA2 and GluA3 also undergo
activity dependent exocytosis to the postsynaptic membrane in the mature
hippocampus (Adesnik and Nicoll, 2007). Protein-protein interaction play a key role
in GluA2/3 exocytosis. This involves a large molecular complex involving direct
and indirect interactions of GluA2/3 with GRIP1/GRIP2, PICK1, KIBRA, Grasp1
and NSG1 (Anggono and Huganir, 2012).

AMPARs in LTD: During depression of synaptic strength the balance between
AMPAR endo- and exocytosis is shifted towards endocytosis leading to reduced
numbers of AMPARs in the postsynaptic membrane (Huganir and Nicoll, 2013).
AMPAR endocytosis can take either the Clathrin or Dynamin routes during LTD
(Shepherd and Huganir, 2007). In contrast to LTP where GluA1 phosphorylation
plays an important role, GluA2 phosphorylation is important in LTD. LTD is
suppressed in a mice model carrying a phopho- null mutation, where GluA2
phosphorylation is eliminated (Chung et al., 2000; Steinberg et al., 2006). As
mentioned above in the case of LTP, a molecular complex involving GluA2’s
interaction with GRIP1/GRIP2 and PICK1 mediates its membrane trafficking. This
is demonstrated by the loss of LTD upon genetic ablation of GRIP1/GRIP2 or
PICK1 (Chung et al., 2000; Seidenman et al., 2003; Steinberg et al., 2006;
Takamiya et al., 2008). Specifically, it was shown that phosphorylation of the Ctermini of GluA2 weakens its interactions with GRIP/PICK1 and allows for GluA2
internalization (Chung et al., 2000; Seidenman et al., 2003; Steinberg et al., 2006)
While GluA2 has a dominant role in LTD, GluA1 has also been shown to be
important. Unlike LTP however, GluA1 de-phosphorylation appears to be more
important. A mutation resulting in a continuous phosphorylation of S845 appears
to prevent LTD (Lee et al., 2009).

AMPARs in homeostatic plasticity: Neurons appear to have a physiological
range of activity. Homeostatic plasticity refers to the increase or decrease in the
number of postsynaptic AMPARs in order to maintain activity around this set point.
5

For example, when neurons are subject to hyperactivity by blocking GABA
receptors (Bicuculine treatment), it results in scaling down of AMPARs. Similarly,
chronic hypoactivity caused by blocking sodium channels (TTX treatment) leads
to a homeostatic scaling up resulting in increased number of postsynaptic
AMPARs (Turrigiano et al., 1998; Turrigiano, 2008). Similar to LTP and LTD,
synaptic strength is altered during homeostatic scaling by changing the abundance
of postsynaptic AMPARs, subunit composition, protein interactions, and PTMs
(O’Brien et al., 1998). One common method is the induction of homeostatic
upscaling via chronic (24-48hr) treatment of cultured neurons with tetrodotoxin
(TTX). This causes increases in GluA1 protein expression as well as surface and
synaptic levels of AMPARs (Soares et al., 2013; Kim and Ziff, 2014). While the
general principles of AMPAR trafficking to or from the membrane appear shared
between long term and homeostatic plasticity, the specifics may vary. For example,
scaling up of GluA1, like in LTP, involves phosphorylation. More specifically
however, LTP involves phosphorylation of GluA1 residue S845. In the case of a
mutant where S845 is constitutively phosphorylated, scaling up occurs upon
chronic TTX treatment however the GluA1 does not recruit specifically at synapses
(Diering et al., 2014; Kim and Ziff, 2014). Similarly, the GluA2 molecular complex
with GRIP1/GRIP2 and PICK1 also plays an important role in scaling up (Gainey
et al., 2009). For example, shRNA mediated knockdown or blockade of GluA2
functions by the introduction of a competing C termini can block homeostatic scale
up. Curiously, in addition to the overlap in the molecular principles adopted to
deliver or AMPAR, there also seem to be functional redundancy among the
AMPAR subunits. to there appears to be redundancy inherent to homeostatic
scaling. For example, homeostatic scaling of GluA1/3 can still be observed when
GluA1 is knocked out, however GluA1 surface levels are found to increase upon
GluA2/3 knockout (Altimimi and Stellwagen, 2013).

PDZ domain containing AMPAR interacting proteins
All of the AMPAR subunits share a consensus (-SVKI) sequence at their Cterminus end. This conserved motif has been shown to facilitate their interaction
6

with PDZ domain containing proteins (Dong et al., 1997). In this instance, the GRIP
family of proteins including GRIP1, GRIP2 and AMPAR-binding protein (ABP) are
of particular relevance to NSG proteins (Dong et al., 1997; Srivastava et al., 1998).
Interestingly, GRIP not only functions in the PSD but also binds to the motor protein
KIF5 and regulates AMPARs during short and long-range trafficking. This is
demonstrated by the effects on surface expression of AMPARs upon GRIP1/2
overexpression or knockout. Mice carrying a gain of function mutation in GRIP1
show faster AMPAR recycling and heightened surface expression. On the
contrary, decreased surface AMPARs is seen in mice with GRIP1/2 knockout
(Mejias et al., 2011; Han et al., 2017). When AMPAR endocytosis is promoted
either by an LTD like stimulus or AMPA treatment, internalized AMPARs are
tethered and sequestered intracellularly (Daw et al., 2000; Braithwaite et al., 2002;
Hirbec et al., 2003). Alternatively, GRIP1 may also regulate AMPAR recycling and
insertion back into the membrane (Mao et al., 2010). NMDA stimulation of neurons
also leads to GluA2 internalization. Recycling GluA2 back to the membrane
followed by its reinsertion was shown to be regulated by GRIP1 (Lu and Ziff, 2005).
These examples further exemplify the role of the GRIP proteins in regulating
AMPAR trafficking (Hayashi and Huganir, 2004).

The post synaptic density
The PSD of glutamatergic synapses is usually located at the tip of the
dendritic spine, a region called the spine head. Dendritic spines are tiny 0.5–2 μm
actin rich membrane protrusions. There appears to be a correlation between the
size of the spine head with the synaptic strength with larger ones expressing more
number of AMPAR (Kasai et al., 2003). The majority of excitatory synapses of
principal neurons like the pyramidal neurons of the mammalian hippocampus
occur at 1–10 spines/μm of dendrite length. The heterogeneous spines come in
various shapes such as ‘thin filopodia’, ‘stubby’ or ‘mushroom’. However these
shapes are not fixed and display significant plasticity in size, shape and number
depending on the stage of neural development and strength of synapses and also
show dynamic motility during development (Kasai et al., 2003; Ethell and
7

Pasquale, 2005; Tada and Sheng, 2006). Interestingly, subjecting the mice to new
experiences leads to sprouting of new dendritic spines (Holtmaat et al., 2006).
Glutamate uncaging through photolysis revealed potentiation of AMPAR current at
a single spine as a consequence of quantal uncaging which was correlated with
an increase in the volume of the spine head (Kasai et al., 2003; Holtmaat et al.,
2006).
The identity of the protein complex of the cerebral cortex PSD was first
elucidated in the 1990s using a combination of 2D gel electrophoresis and Nterminal peptide sequencing. An initial set of 30 proteins were identified which
included two proteins associated with vesicular trafficking, dynamin and Nethylmaleimide-sensitive factor (Walsh and Kuruc, 1992). Cho et al (1992) showed
that the prototypic PSD protein post-synaptic density of 95 kDa (PSD95) enriched
in the rat PSD shares sequence similarity with the Drosophila tumor suppressor
protein discs-large-1 (dlg) (Cho et al., 1992). Antisera based screening of brain
cDNA expression libraries, yeast two hybrid based screening of rat brain cDNA
library and the advent of Mass spectrometry (MS) revolutionized protein discovery
and led to the identification of hundreds of putative PSD proteins with known or
unknown functions (Langnaese et al., 1996; Collins et al., 2006; Yoshimura et al.,
2004). These methods allowed for a better understanding of the molecular
mechanisms underlying PSD’s role in synaptic plasticity. The PSD proteins can be
generally grouped into several functional categories like cytoskeletal and actin
related, kinases/phosphatases, receptors and channels, membrane trafficking and
motor proteins, cell adhesion, GTPases and regulators, metabolism, scaffolds and
translation (Sheng and Kim, 2011).

Protein Signaling in the PSD
Signaling molecules and scaffolding molecules taken together as a group
make up a large part of the PSD. Among the signaling molecules the most
abundant are the kinases which include the CamKIIα and non-receptor tyrosine
kinases. These are followed by phosphatases like the serine/threonine protein
phosphatase I and protein tyrosine phosphatases (Sheng and Hoogenraad, 2007).
8

NMDA

receptor

stimulation

promotes

calcium/calmodulin

dependent

phosphorylation and recruitment of CamKII into the PSD (Bayer et al., 2001)
leading to activity dependent potentiation of the PSD via synaptic recruitment of
GluA1 (Hayashi et al., 2000). Activity dependent Ca2+ influx through the NMDAR
allows for formation of new spines as well as strengthening of existing ones via a
process involving a multiprotein signaling complex (Saneyoshi et al., 2008).

Scaffolding proteins of the PSD
Scaffolding proteins in the PSD serve as a platform to hold together an
enriched array of postsynaptic receptors and cytoplasmic signaling proteins like
protein kinases, phosphatases, cell adhesion molecules and GTPases (Sheng and
Hoogenraad, 2007). One of the better characterized scaffolding proteins includes
Membrane associated guanylate kinases.

Membrane associated Guanylate Kinases (MAGUKs): One of the most studied
and best characterized family of scaffolding proteins are the MAGUKs. The PSD95
family of MAGUK proteins and have been implicated in diverse aspects of synaptic
plasticity and structural integrity of the PSD. The family includes four proteins,
PSD-95, PSD-93, SAP102, and SAP97 that share highly conserved structural
domains (Sheng and Hoogenraad, 2007). Their protein interaction domains help
in integrating external cues from cell surface receptors or channels and adhesion
molecules with intracellular signals and cytoskeletal components. The prototypic
MAGUK PSD95 was one of the first identified constituents of the PSD from rat
brain (Cho et al., 1992), and its relevance in sustaining the 3D architecture of the
PSDs became apparent with the EM tomography based observation that RNAi
mediated PSD95 knockdown led to the loss of entire patches of PSD (Chen et al.,
2011). The importance of MAGUKs in anchoring AMPAR and NMDAR in the PSD
stems from a study by Chen and colleagues (2011) involving chained knockdown
of PSD-95, PSD-93 and SAP102. EM tomography results from this study show a
significant reduction in the size of PSDs and a disintegration of the molecular fabric
that organizes these glutamate receptors (Chen et al., 2011). Parallel
9

electrophysiology experiments showed that triple MAGUK knockdown significantly
diminished AMPA and NMDA currents and gave rise to silent synapses (Chen et
al., 2015). Immunogold electron microscopy studies showed that the number of
AMPAR at a PSD has a linear correlation with the size of the PSD. 75% of the
synapses from adult rat Schaffer collateral-commissural synapses contained both
NMDAR and AMPAR and the size of these synapses were correlated to the
number of AMPAR. Silent synapses which did not have AMPAR but only NMDA
receptors were significantly smaller in size. This heterogeneity in synapse size and
AMPAR was not observable in mossy fiber synapses (Takumi et al., 1999).
Curiously, when Lu and colleagues (2013) knocked out AMPAR from the CA1
synapses using Cre-Lox recombination in Gria1-3-/- Grin1-/- mice, they did not
observe any morphological differences in the CA1 synapses despite not having
any glutamatergic transmission (Lu et al., 2013). These observations indicate that
while the size of the synapse is an indicator of synapse strength, the AMPAR
complement may only have a small contribution to of synapse size. In the case of
AMPAR, PSD95 indirectly interacts with AMPAR via the Transmembrane AMPA
regulatory protein (TARP), stargazing (stg) (Chen et al., 2000). A deletion of the
PDZ-binding domain in stg disrupts hippocampal synapses resulting in a decrease
in AMPA mini EPSC amplitude and frequency in hippocampal neurons (Chen et
al., 2000). Considerable redundancy in functions is observed among the various
MAGUK family members. While overexpression of PSD95 increased both the
number and size of synapses evident in the increase amplitude and frequency of
AMPA mEPSCs (El-Husseini et al., 2000; Stein et al., 2003), genetically inactive,
truncated PSD95 did not alter AMPAR synaptic transmission (Migaud et al.,
1998)). Interestingly, RNA interference mediated knockdown of PSD95 in cultured
hippocampal neurons resulted in a 42% reduction in GluA2 localization in dendritic
spines compared to control and a significant reduction AMPA mini EPSC
frequency but curiously no change in the amplitude (Levy et al., 2015). Similarly,
AMPAR EPSC recordings from hippocampal slices expressing the shRNA for
PSD95 showed a 51% reduction in amplitude compared to scrambled shRNA
(Elias et al., 2006). Similar effects were observed for acute knockdown of PSD93
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with a 48% reduction in AMPAR EPSC amplitude in hippocampal slices compared
to control (Elias et al., 2006). In order to overcome the functional redundancy and
definitively identify the functional contribution of each MAGUK family member in
synaptic transmission Elias and colleagues (2006) generated a PSD93/95 double
KO mouse. AMPAR current recordings from hippocampal slices from this mouse
also showed a 55% reduction in EPSC amplitude and corresponded with a
significant reduction of GluA1 and GluA2 receptors in a PSD enriched fraction
(Elias et al., 2006). While each of PSD95 and PSD93 resulted in an ~50%
reduction in evoked AMPA EPSC amplitude, the combined knockout also resulting
in a 50% reduction was indicative of compensation from another MAGUK family
member. This was indeed the case, as an shRNA mediated knockdown of SAP102
in hippocampal slices from PSD93/PSD95 double KO mouse further decreased
the amplitude of AMPA EPSC to ~80% of WT and the PSD fractions of double KO
mice were also enriched in SAP102 (Elias et al., 2006). These studies suggest that
MAGUKs are not only compensate for the functions of a missing family member
as indicated by studies in the germ line KO mice but are critical for targeting nearly
all glutamate receptors (AMPAR and NMDARs) to the synapse.

The Neuron Specific Gene (NSG) family: Candidates for AMPAR
trafficking
The NSG family of orthologous genes encode for the three closely related
neuron‐enriched endosomal proteins, NSG1 (also NEEP21), NSG2 (also
HMP19/Neuronal Vesicle Trafficking Associated/Protein P19) and NSG3 (also
Calcyon/Caly). NSG1 and NSG2 were originally discovered through cDNA library
based screens for genes expressed in embryonic rat brains (Saberan-Djoneidi et
al., 1995; Saberan-Djoneidi et al., 1998). NSG3 was identified through a yeast two‐
hybrid screening of the human brain cDNA library (Lezcano et al., 2000). Evidence
from previous research points to the evolution of the NSG gene family (also
NEEP21/Caly/p19 family) as important vesicular trafficking mediators in neurons
during early vertebrate speciation, as flies and worms don’t express NSG proteins.
Northern blots demonstrated enrichment of NSG transcripts in the brain (Saberan11

Djoneidi et al., 1995; Saberan-Djoneidi et al., 1998; Lezcano et al., 2000). The
tripartite family of proteins are thus highly enriched in the central nervous system
and show very little expression in other tissues, although some expression is seen
in testes. NSG1 and NSG2 are highly developmentally regulated with peak
expression shown to be around Embryonic day (E) 17 and heightened expression
up to the first postnatal week (Saberan-Djoneidi et al., 1995; Saberan-Djoneidi et
al., 1998).

Molecular Structure of NSG Family Members
All NSG family proteins have a single TM domain and a highly conserved
47 amino acids residue immediately adjoining the TM region on the C-terminus.
Outside of this unique motif, sequence comparison studies suggest a greater
conservation at the N-terminus region and more divergence at the C-termini. NSG1
and NSG3 have previously been shown to carry out distinct roles in intracellular
vesicular trafficking including in post synaptic AMPA receptor endocytosis,
recycling, and degradation. Co-immunoprecipitation studies showed that NSG1
specifically bound the GluA1 and GluA2 subunits and regulated the recycling of
AMPA receptors at mature excitatory glutamatergic synapses (Steiner et al., 2002;
Steiner et al., 2005), transcytosis of adhesion protein L1CAM to axons (Yap et al.,
2008) and processing of beta-amyloid precursor protein (Norstrom et al., 2010). In
contrast, NSG3 was shown to be involved in activity dependent clathrin mediated
endocytosis (CME) of AMPA receptors at excitatory synapses (Xiao et al., 2006a;
Davidson et al., 2009a) and proteolytic cleavage of Neuregulin 1 (Yin et al., 2015).
Together, NSG family proteins sub serve roles in neuron development, synaptic
function, and neurodegeneration.

Cellular localization and trafficking dynamics
The subcellular localization of NSG1, NSG2 and NSG3 has been examined
in neurons, using both the light microscope and at high resolution using the
electron microscope. Immunofluorescence assays revealed that these proteins are
enriched in the trans-Golgi network (TGN) and distributed as puncta within neurons
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(Saberan-Djoneidi et al., 1995; Saberan-Djoneidi et al., 1998; Xiao et al., 2006;
Yap et al., 2017). However, while NSG1 showed a predominantly somatodendritic
vesicular localization (Steiner et al., 2002), NSG3 was distributed throughout the
neurons including in the axons (Xiao et al., 2006). In electron micrographs NSG1
and NSG3 proteins appear within endosomal vesicles and interestingly both within
and at the base of dendritic spines. While NSG1 appears to be localized within
multivesicular bodies and also near the PSD, NSG3 is usually along the wall of the
dendritic spine lateral to the PSDs (Xiao et al., 2006; Utvik et al., 2009). Steiner
and colleagues (2002) used immunocytochemical labeling and found that NSG1
was localized in Rab5+ early endosomes (EE’s), in Rab4/5+ sorting endosomes. A
smaller subset of NSG1 localized in Rab11+ recycling endosomes (REs)(Steiner
et al., 2002). Curiously, they did not present any quantitative data and was mostly
qualitative. More recently, Yap and colleagues (2017), have shown that both NSG1
and NSG2 are co-localized in EEA1+ and Rab5+ EEs. Overexpression of the
constitutively active Rab5 (Rab5-Q79L) led to the accumulation of both NSG1 and
NSG2 in enlarged somatic and dendritic endosomes due to excessive fusion of
endosomes. In contrast, overexpression of the dominant negative Rab5 (Rab5S34N) resulted in a loss of NSG1 and NSG2 punctate endosomal staining resulting
in diffuse staining in the transfected cell. Consistent with earlier findings both NSG1
and NSG2 were found to minimally localize to Rab11 + and Transferrin+ (Tf) REs.
Finally, in contrast to previous reports suggesting that NSG1 may occupy a unique
set of neuron specific endosomes, they have shown that a significant subset of
NSG1 and NSG2 are trafficked from Rab5+ EEs to Rab7+ late endosomes (LEs)
and eventually targeted for degradation in LAMP1+ lysosomes. Overexpression of
the dominant negative (Rab7-T22N) in cultured neurons resulted in increased
NSG1 and NSG2 staining intensities compared to untransfected neurons. Similar
accumulation of NSG1 and NSG2 was observed upon shRNA mediated
knockdown of Rab7 (Yap et al., 2017). These findings of NSG1 and NSG2 entering
LEs after endocytosis through Rab5 EEs and not recycling via Rab11 + REs are
intriguing in light of previous reports implicating NSG1 as a critical mediator of
recycling post synaptic AMPA receptors. NSG3 has previously been shown to
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localize in EEA1+/Rab5+ EEs consistent with its role in activity-induced endocytosis
of postsynaptic AMPA receptor (Xiao et al., 2006; Davidson et al., 2009). However,
more recently NSG3 has also been shown to be localized and trafficked in Rab7 +
LEs and LAMP1+ lysosome related organelles (LROs) in neuronal axons (Shi et
al., 2018). Interestingly, all proteins have also been shown to be expressed at the
cell surface. NSG3 was shown to be expressed in the surface of HEK293 cells in
unstimulated condition. Surface expression was mediated by cytoskeletal proteins
as blocking microtubule polymerization with Nocadazole reduced surface NSG3
(sNSG3) expression. Pharmacological perturbation of intracellular calcium levels
also impacted sNSG3 expression, for example sNSG3 was increased by treatment
with Thapsigargin that elevates intracellular calcium levels and KN62 dependent
block of CAMKII activity reduced sNSG3 (Ali and Bergson, 2003). NSG1 and
NSG2 have also recently been shown to be expressed on the surface of neurons
(Yap et al., 2017).
Live cell imaging studies have further revealed the dynamic shuttling of
NSG proteins within cells. These movements are thought to be facilitated by
microtubule associated motor proteins. Yap and colleagues (2017) carried out
simultaneous live imaging of both NSG1-mcherry and NSG2-GFP in cultured
neurons and showed ~60% co-localization and co-trafficking of both proteins in the
stationary and motile endosomal population. The motile puncta displayed dynamic
antero- and retrograde motion along dendrites and a small proportion of NSG
puncta reversed direction (Yap et al., 2017). Further, they showed that surface
NSG1 and NSG2 first get endocytosed and co-traffic within Rab5+ EE
compartment which then are transferred into Rab7+ LE compartment (Yap et al.,
2017). Similarly, NSG3 vesicles have also been shown to be dynamically trafficked
in HEK 293, SH-SY5Y and Neural cells. For example, TIRFM imaging of HEK 293
cells overexpressing mVenus-NSG3 was used to confirm its cell surface
localization. Interestingly, sNSG3 displayed spontaneous lateral and vertical
movements even on the cell surface (Ali and Bergson, 2003; Shi et al., 2017). Live
cell imaging of endocytosis of sNSG3 was confirmed by treating surface proteins
with WGA-Alexa Fluor (AF-594), which binds to plasma membrane proteins and
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remains bound even during cellular uptake. NSG3 and WGA were co-trafficked to
the Golgi apparatus. Further it also showed that mVenus-NSG3 puncta showed
dynamic bidirectional movement within dendrites for variable distances as seen
with NSG1 and NSG2. The movement was also shown to be temperature sensitive
and could be arrested by transitioning the cells during imaging from 37⁰C to 15⁰C.
Movement could also be arrested by treating the cells with the microtubule
polymerization inhibitor nocodazole demonstrating that NSG3 vesicular transport
is microtubule dependent (Shi et al., 2017). Thus NSG family of proteins appear to
be critical for a variety of intracellular vesicular trafficking events including at
excitatory synapses.

Endosomal Trafficking and interacting adapters
NSG1 and NSG3 have been shown interact and/or associate with a unique
complement of proteins that determine their unique roles in endosomal trafficking.
Steiner and colleagues first identified NSG1 as a molecule that co-purified with the
SNARE protein Syntaxin13 (Stx13) from early postnatal rat brain (Steiner et al.,
2005a). SNARE proteins have demonstrated roles in endosomal vesicle fusion and
docking. Stx13 has been shown to be associated with REs and play an important
role in regulating the recycling of Tfn receptors and neurite outgrowth (Prekeris et
al., 1998; Hirling et al., 2000). Steiner and colleagues (2005) also demonstrated
that NSG1 binds to the Glutamate Receptor Interacting Protein 1 (GRIP1) via a Ctermini binding domain (aa 129-164). NSG1’s interaction with Stx13 is thus
facilitated by a molecular complex involving NSG1/GRIP1 associated with the
bridging molecule GRIP1-associated protein 1 (GRASP1) which is associated with
REs (Hoogenraad et al., 2010). Several proteomic approaches including yeast two
hybrid and mass spectrometry based approaches have identified the protein
interactions partners of the C-terminus of NSG3. Most interacting partners appear
to facilitate NSG3’s role in CME, for example its binding with the clathrin light chain
regulates clathrin assembly. The purified NSG3 C-terminus appears to promote
clathrin self-assembly in vitro (Xiao et al., 2006). However, there is significant
reduction in steady state levels of assembled clathrin in vivo in a NSG3 KO mouse
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model suggesting that NSG3 clathrin light chain interactions are critical for clathrin
coated vesicle formation in the brain. NSG3 C-terminus also stably interacts with
the µ subunits of the clathrin adapter proteins AP-1, AP-2 and AP-3 (Muthusamy
et al., 2012). These adapter proteins have been implicated in various endosomal
trafficking functions ranging from sequestering cell surface cargo destined for
internalization to facilitating forward trafficking from TGN to REs and reverse
trafficking from EEs to LEs and Lysosomes (Bonifacino and Traub, 2003; NewellLitwa et al., 2007)

NSG1 and NSG3 have unique trafficking roles
The complementary and unique vesicle trafficking roles of NSG1 and NSG3
is clearly demonstrated in the case of Tfn, which localizes to the somatodendritic
regions in neurons (West et al., 1997). Tfn which is internalized through CME can
be recycled via one of the following kinetically distinct trafficking routes: A) the
faster route involving the Rab4/Rab5+ sorting endosomes (SEs) or, B) the slower
Rab4/Rab11+ REs. Tfn adopts the faster route demonstrated by the fact that
treating the cells with wortmannin results in Tfn accumulation in enlarged
Rab4/Rab5+ vesicles consequently resulting in a significant delay in Tfn recycling
(Sheff et al., 1999; Trischler et al., 1999). In contrast, treatment with brefeldin A
increases tubulation of Rab4/Rab11+ REs which however, do not significantly
accumulate Tfn and only cause a minor delay in Tfn recycling (Klausner et al.,
1992; Sönnichsen et al., 2000). While anti-sense mediated NSG1 knock down
delays recycling of internalized Tfn. Overexpression alters both Tfn recycling and
internalization (Steiner et al., 2002). Comparatively, NSG3 KO and overexpression
only alter Tfn internalization but not recycling (Xiao et al., 2006). Other examples
of NSG1 and NSG3’s role in recycling and endocytosis emerges from the study on
the G-protein coupled Neurotensin receptor 1 (NTS1R) and Dopamine receptor
D1 (D1DR). NTS1R and NTS2R have independent trafficking pathways. While
NTS1R gets sorted to the degradative lysosomes after endocytosis through the
EE pathway, the NTS2R recycles back to the plasma membrane through both the
recycling pathways mentioned above for Tfn. Debaigt and colleagues (2004)
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showed that overexpression of NSG1 in COS7 cells causes NTS1R to resort to a
recycling pathway. One likely explanation could be that excess NSG1 redirects the
trafficking of NTS1R from a degradative fate to a recycling fate through one of the
recycling pathways similar to the effects of NSG1 overexpression on Tfn (Debaigt
et al., 2004). The opposite effect of increased degradation of internalized NTS1R
is seen upon knockdown of NSG1. In the case of D1DR, Ha CM and colleagues
(2012) showed that NSG3 forms a ternary complex with the synaptic scaffolding
protein PSD95 and D1DR. Phosphorylation of the Ser169 residue of NSG3 as a
consequence of activation of the protein kinase C (PKC) with a phorbol myristate
acetate combined with the D1DR agonist SK81297 not only resulted in recruitment
of NSG3 at the plasma membrane and increased interaction with PSD95 but also
increased internalization of the D1DR. This effect on D1DR internalization was
nullified when the NSG3 phospho-deficient mutant S169A was used (Ha et al.,
2012a). These observations are strongly suggestive of NSG1’s role in the RE
pathway and opposed to NSG3 which has been shown to be a critical regulator of
endocytosis.

NSG proteins in AMPA receptor trafficking
A logical question that emerges from the observation that NSG1 and NSG3
are involved in various aspects of vesicular trafficking and localize in excitatory
spine synapses is whether the NSG family of proteins are involved in regulating
excitatory synaptic transmission and synaptic plasticity. Evidence from previous
studies involving perturbation of the levels of NSG1 and NSG3 in cells support
their role in post-synaptic AMPA receptor trafficking and synaptic plasticity.
NMDA/TTX and AMPA stimulation enhances internalization and recycling of
AMPA receptors (Ehlers, 2000; Lee et al., 2004). However, NMDA stimulation
alone without TTX induces sorting to the degradation pathway (Lee et al., 2004).
Davidson and colleagues (2009) showed that cultured neurons from a NSG3 KO
mouse show impaired AMPA receptor subunit GluA1 and GluA2 internalization
upon simulation of LTD like conditions using AMPA or NMDA treatment compared
to cultured neurons from wild-type mouse. Similarly, mEPSC recordings from
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NSG3 KO cultures did not indicate any difference in basal glutamatergic
transmission (Davidson et al., 2009). There were also no differences between the
two groups in AMPA/NMDA ratio, AMPA and NMDA‐dependent I/V relationships
or pre-synaptic neurotransmitter release probability. EPSC recordings from acute
hippocampal slices of NSG3 KO mouse also showed a deficit in the internalization
of AMPA receptors in the CA1 cells upon induction of LTD using Low Frequency
Stimulus (LFS) of the Schaffer Collaterals, again suggesting an impairment in the
AMPA receptor internalization (Davidson et al., 2009). This deficit could also be
mimicked by titrating a peptide containing the Caly CLC‐binding domain (GST‐
Cal123–155) into wild‐type CA1 neurons via the patch pipette. The defects in
AMPA receptor internalization upon LFS simulated LTD could be rescued by
overexpressing NSG3 (Davidson et al., 2009). These effects on AMPA receptor
internalization are likely modulated indirectly by NSG3’s effects on CME which has
previously been shown to be involved in AMPA receptor endocytosis (Kastning et
al., 2007).
Results from several previous studies indicate that NSG1 is also an
important player in the AMPA receptor recycling. A predicted role of NSG1 in
AMPA receptor recruitment and/or subunit exchange at synapses during postnatal
development and during synaptogenesis stems from the fact that NSG1 mRNA
(Saberan-Djoneidi et al., 1998) and protein (Steiner et al., 2002) is highly
expressed between the first weeks post conception to the first postnatal week. This
is when AMPA receptors are recruited to hippocampal synapses with the
proportion

of

NMDAR+AMPAR-

synapses

decreasing

to

give

rise

to

NMDAR+AMPAR+ synapses. This is also accompanied by a switch of GluA4
receptor subunits to GluA4 (Diering and Huganir, 2018). Concrete evidence of
NSG1 involvement in AMPA receptor trafficking emerged from work from the
Hirling group. While anti-sense mediated down-regulation of NSG1 retarded
recycling of GluA1 and GluA2 (to a smaller extent) after NMDA application,
internalized AMPA receptors which feeds into the RE pathway resulted in
significant co-localization between NSG1 and GluA2. Stimulation that fed into the
degradative pathway did not show this. Anti-sense mediated NSG1 knockdown or
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a purified C-terminal fragment of NSG1 (aa129‐164) served as a dominant
negative affected both AMPA mEPSC and evoked AMPA EPSC. The effect of
decreased mEPSC amplitude was specific and did not affect NMDA receptors or
pre-synaptic release properties. Further, a high frequency stimulus (HFS)
paradigm for inducing LTP in organotypic hippocampal slices failed to induce the
same extent of potentiation of AMPA EPSC as WT when the patch pipette included
either the anti-sense NSG1 or a purified C-terminal fragment of NSG1 (aa129‐164)
which served as a dominant negative. Finally, AMPA current amplitude did not
increase in NSG1 knock down neurons following inhibition of CME using peptide
D15 (Alberi et al., 2005). Together, these effects suggest NSG1 promotes both
constitutive and activity‐dependent AMPA receptor recycling. Probing for a
potential molecular mechanism for NSG1’s regulation of AMPA receptor recycling
led to the identification of the regulated multi-molecular complex involving
interactions between NEEP21, GRIP1, GluR2 and syntaxin 13 (Steiner et al.,
2005). GRIP1, a type II PDZ protein localizes to both the plasma membrane and
intracellular compartments and importantly in dendritic spines. NSG1 was shown
to bind GRIP1 via the C‐terminal domain that contains PDZ repeat 7 in GRIP1. On
the other hand AMPA receptor subunit GluA2 interacts with the GRIP1 PDZ
repeats 4 and 5. Competitive blockade of the interaction between NSG1 and
GRIP1 by transfecting neurons with an NSG1 GRIP1 binding domain (aa129-164)
prevented GluA2 recycling under both unstimulated and stimulation to promote
AMPA receptor internalization. Curiously, this effect was found to be specific for
GluA2 and baseline surface expression or recycling of GluA1 was not affected.
Further, Steiner and colleagues, used co-immunoprecipitation and found
enhanced complex formation of GRIP1/GluR2 and NSG1 under AMPA receptor
recycling stimulation, while it is decreased under conditions that stimulate AMPA
receptor degradation. Finally, Kulangara and colleagues (2007) discovered a novel
kinase associated with NSG1 that phosphorylates GRIP1. They showed that the
phosphorylating activity of the unknown kinase was targeted to Ser 917 and was
regulated by NMDA and AMPA treatments. The model that emerged from this
study suggests that while dephosphorylated GRIP1 associates with NSG1 thus
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facilitating its interaction with GluA2 in endosomes, rephosophorylation of GRIP1
destabilizes its interaction with NSG1 thus allowing GluA2 to recycle back to the
plasma membrane (Kulangara et al., 2007).

Alternate trafficking pathways and protein interactions
Yap and colleagues (2008), showed that NSG1 is involved in transcytosis
(trafficking back from the somatodendritic region into axons) of the cell adhesion
molecule L1/neuron‐glia cell adhesion molecule (L1/NgCam) (Yap et al., 2008).
While L1/NgCam is typically enriched in the axon, it accumulates in the
somatodendritic region of neurons when NSG1 is knocked down consequently
resulting in less accumulation of L1/NgCam in axons. Live cell imaging studies
revealed that L1/NgCam transiently co‐localizes with NSG1+/Tfn+ stationary
vesicles prior to transitioning into motile NSG1+/Tfn- vesicles. Their data suggests
that NSG1 facilitates sorting of axonal cargo via transcytosis and diverts cargos
from a degradative pathway. Similarly NSG3 is also involved in axonal cargo
transport. NSG3 has been shown to interact with the μ3 subunit of AP‐3
(Muthusamy et al., 2012). AP‐3 increases sorting of cargos from somatodendritic
Tfn+ endosomes to axons (Newell-Litwa et al., 2007). In NSG3 KO mice, significant
deficits are observed in the targeting of two AP‐3 cargos phosphoinositol‐4‐
phosphate kinase IIα and zinc transporter 3 in the mossy fibers of the dentate gyrus
(Salazar et al., 2004; Seong et al., 2005).
Thus, the preponderance of evidence points to an important contribution of
the NSG family in various aspects of protein trafficking and processes involved in
neuronal development and function. Critically, NSG family members NSG1 and
NSG3 have been shown to mediate vesicular trafficking events that serve to
regulate AMPAR turnover at the cell surface during both basal and activity
dependent synaptic transmission. Curiously, the role of NSG2, the founding
member of the family based on evolutionary gene ontology, remains unknown. We
discovered NSG2 as one among the highest expressed genes in a high throughput
microarray analysis during heightened synaptogenesis. Incidentally, NSG2’s
expression profile closely resembled the expression profile for AMPAR encoding
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genes Gria1 and Gria2 and hypothesized that NSG2 may have a role in regulating
AMPAR trafficking at synapses during neural development (Figure 1).

HYPOTHESIS:

Figure 1: Diagrammatic summary of hypothesized role of NSG2 in PSDs. (Left) Summary of
previous research showing NSG3 (Yellow) involved in endocytosis of AMPAR (blue/red) from the
cell surface via early endosomal vesicles (EE) and NSG1 (magenta) sorting of internalized
AMPARs into either the lysosomes (Lys) or recycling endosomes (RE). Based on developmental
expression, that NSG2 (cyan) primarily affects trafficking of AMPARs at nascent synapses (right),
but may also function at more mature synapses (left) in the final secretory process to promote
surface expression.
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Chapter 2: Neuron-Specific Gene 2 (NSG2) encodes an AMPA
receptor interacting protein that modulates excitatory
neurotransmission
Introduction
As mentioned, the function of NSG2 (also termed Neuronal Vesicle
Trafficking-Associated 2) remains unknown. However, based on the function of
other NSG family members (NSG1 and NSG3) (Muthusamy et al., 2009; Norstrom
et al., 2010; Lasiecka et al., 2014), we can make some hypotheses as to how
NSG2 affects neuronal excitability. One major function attributed to both NSG1
and NSG3 is the regulated trafficking of the AMPA-type glutamate receptors
(AMPARs) at postsynaptic densities (PSDs) during neuronal activity that leads to
changes in synaptic efficacy (reviewed in (Yap and Winckler, 2012; Muthusamy et
al., 2015). For instance, Calcyon is found in RAB5+/EEA1+ early endosomes,
interacts with AP2 and AP3, and is critical for clathrin-mediated endocytosis of
AMPARs (Xiao et al., 2006; Muthusamy et al., 2012; Muthusamy et al., 2015).
Knockout of Calcyon impairs long term depression (LTD)-mediated AMPAR
endocytosis, while overexpression reduces GluA1 and GluA2 surface expression
and impairs performance on a fear extinction paradigm (Xiao et al., 2006;
Kruusmägi et al., 2007; Davidson et al., 2009; Vazdarjanova et al., 2011). NSG1,
on the other hand, is colocalized to a limited extent with early endosome marker
RAB5 and recycling endosome marker RAB11 (Steiner et al., 2002; Yap et al.,
2017). Overexpression of the carboxy (C)-terminal tail of NSG1 acts as a dominant
negative and prevents recycling of GluA1/2-containing AMPARs following NMDAmediated internalization (Alberi et al., 2005; Steiner et al., 2005). Together these
proteins play complementary roles in regulating internalization (Calcyon) and
recycling (NSG1) to promote AMPAR sorting between intracellular compartments
and the plasma membrane during synaptic plasticity at established synapses.
NSG2 is expressed widely throughout the brain (Saberan-Djoneidi et al., 1995)
with significant overlapping expression but some degree of divergence with NSG1
(Barford et al., 2017); the expression of NSG3 remains unknown. At the cellular
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level, NSG2 is found extensively localized to the trans-Golgi network as well as in
dendritic endosomes, and was recently found to be expressed transiently at the
cell surface, similar to NSG1 (Yap et al., 2017). Interestingly, NSG2 also contains
a secretogranin III domain as well as an atypical EGF-like motif (Saberan-Djoneidi
et al., 1995), making it a good candidate for regulating signaling and exocytosis.
We therefore hypothesized that NSG2 is a novel AMPAR binding protein that
complements the NSG3 (endocytosis) and NSG1 (recycling) vesicular trafficking
functions and thus regulates AMPAR surface recycling/expression.
Interestingly however, human NSG2 shares only 50% sequence homology
with NSG1 and a 30% sequence homology with Calcyon at the amino acid level
(Muthusamy et al., 2009), and therefore likely has unexpected roles in synaptic
development and plasticity. NSG2 is one of the most highly expressed transcripts
and proteins during human neural differentiation and synapse formation (Kang et
al., 2011; Miller et al., 2014; Barford et al., 2017; Murillo et al., 2017). Thus, in
addition to AMPAR exocytosis, the predominant expression of NSG2 during early
periods of development (Saberan-Djoneidi et al., 1995; Barford et al., 2017) led us
to consider whether it may function during early periods of synaptogenesis.
Here we report that NSG2 is a critical regulator of neuronal AMPAR surface
expression in hippocampal cultures during early periods of neuronal development.
In agreement with previous reports (Yap et al., 2017), we found NSG2 strongly
localized to the trans-Golgi network as well as in a punctate pattern selectively in
developing MAP2+ dendrites but excluded from axons. In addition, we now uncover
that a significant proportion of NSG2 punctae co-localized with synaptic markers
including

AMPAR

subunits.

Co-immunoprecipitation

and

capillary

immunoelectrophoresis experiments demonstrated a physical interaction with both
GluA1 and GluA2. Overexpression and CRISPR-mediated knockout of NSG2
altered AMPAR surface expression as well as AMPAR-mediated postsynaptic
currents. These data are the first to demonstrate a role for NSG2 in the regulation
of AMPAR surface expression and implicate NSG2 as a potential partner of
AMPARs in regulated endosomal trafficking in developing dendrites.
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Materials and Methods
Cell culture, Transfection and Transduction: HEK293T cells and Neuro-2a cells
were maintained in DMEM supplemented with 10% fetal bovine serum (FBS) and
1x Penicillin/Streptomycin (Pen/Strep; Thermo Fisher Scientific, Waltham, MA).
Cells at 90% confluence were passaged every 3 days using 0.05% Trypsin
(Thermo Fisher Scientific). HEK293T cells were transfected using the calcium
phosphate method with 10µg plasmid DNA. Neuro-2a cells were transfected using
Lipofectamine

3000

(Thermo

Fisher

Scientific)

as

per

manufacturer’s

recommendation. Hippocampal pyramidal neurons were derived from P0-P1
C57Bl/6J pups (The Jackson Laboratory, Bar Harbor, ME) of either sex. Briefly,
brains were isolated, and the hippocampus was dissected in ice-cold HBSS
solution (Sigma, St. Louis, MO) supplemented with 20% FBS and NaHCO3
(4.2mM), HEPES (1mM; Sigma), pH 7.4. Dissected hippocampi were digested for
10 min with 0.25% Trypsin (Thermo Fisher Scientific). Tissue was washed and
dissociated using fire polished Pasteur pipettes of decreasing diameter in ice cold
HBSS containing DNase (1500 U; Sigma). The cells were pelleted, resuspended
in plating media and plated at a density of 4-5×105 cells/12-mm coverslip (Electron
Microscopy Sciences, Hatfield, PA) coated with poly-Ornithine (0.1mg/ml; Sigma;
Cat. #4638) and laminin (5μg/ml; Thermo Fisher Scientific). Cells were allowed to
adhere for 20 min before addition of 0.5ml of plating media containing Neurobasal
supplemented with 1X B27, 2mM Glutamax, 0.5mg/ml Pen/Strep and 10% FBS
(all from Thermo Fisher Scientific) for the first 24h. Serum was eliminated from this
media after 24h and again replaced after 48h supplemented with 4µM cytosine 1β-d-arabinofuranoside (Ara-C; Sigma). Neurons were fed by replacing half the
volume of spent media with fresh media without serum or Ara-C every week. All
animal procedures were performed in accordance with author’s university animal
care committee’s regulations. Neurons on coverslips were transduced with
lentivirus (MOI 2 - 3) on day 4 in culture for CRISPR studies or day 7 in culture for
NSG2 overexpression studies and assayed at the days indicated in results. Human
pluripotent stem cells (hPSC; line WA09) were maintained in mTesR (Stemcell
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technologies, Vancouver, Canada) and passaged using 1U/ml Dispase (Stemcell
technologies) as per manufacturer’s recommendation once the cells reached 80%
confluence. hPSC-derived neurons (hPSNs) were differentiated from one six well
plate of hPSCs. Briefly, the cells were lifted using Dispase and allowed to grow in
suspension in a T75 flask for 4 days in mTeSR. From Day5 to Day20, cells were
grown in Neural Induction Media (DMEM/F12; Sigma) supplemented with 1x
concentrations of N2, Glutamax and Pen/Strep (Thermo Fisher Scientific) and
2µg/ml heparin (Sigma) to derive neurospheres with 2/3rd volume of media
replaced every other day. On Day 21, 8 to 10 neurospheres were plated
down/12mm glass coverslip in a 24 well dish coated with poly-ornithine and laminin
as described above and allowed to attach for a minimum of 4h before feeding with
0.5 ml Neural differentiation media (50:50 mixture of Neurobasal:DMEM/F12
supplemented with 1x concentrations of N2, Glutamax, Pen/Strep and 10ng/ml of
cAMP [Sigma], BDNF and GDNF [Peprotech, Rocky Hill. NJ] and 100mM ascorbic
acid [Sigma]). Half volume of media was replaced every other day until the
assayed days mentioned in the Results section.
Plasmids and Lentivirus production: Episomal vectors encoding mCherry or
NSG2-mCherry (NSG2-mC) were generated in house by cloning either mCherry
or the open reading frame of human NSG2 (NM_015980.4) in frame with mCherry
into the pCS2+ mammalian expression plasmid (kind gift from Bill Bement, Univ.
of Wisconsin). The NSG1-GFP plasmid was a kind gift from Bettina Winckler (Univ.
of Virginia). The pSIN REP5-GFP-GluA2(R) was purchased from Addgene
(Addgene, Cambridge,MA; Cat. # 24005) and the YFP-GluA1 was previously
described (Sharma et al., 2006). Lentiviral constructs were generated by cloning
either mCherry or NSG2-mC downstream of the Synapsin-1 promoter in the pFCK
plasmid (Dittgen et al., 2004). CRISPR/Cas9 guide RNAs (gRNAs) targeting
mouse NSG2 (NM_008741.4) were generated using the CRSPR design webtool
(https://zlab.bio/guide-design-resources).

and

GCGTGATGAGAGGGACGGTC-3’
CGTCCCTCTCATCACGCCCT-3’)

gRNAs

were
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cloned

(MsNSG2#1:
MsNSG2#2:
into

5’5’-

pL-Crispr.EFS.GFP

(Addgene, Cat. # 57818) into the BsmBI site as previously suggested (Heckl et al.,
2014). Lentivirus were produced in HEK293T cells using Calcium phosphate
transfection of a 15µg total mixture of lentiviral DNA and packaging plasmids
psPax2 and pMD2.G (gifts from Didier Trono, Addgene, Cat. # 12260 and Cat. #
12259 respectively) at a ratio of 3:2:1 for lentivirus production. 36-48h post
transfection lentivirus containing media was harvested and concentrated using
Lenti-X concentrator (Clontech, Mountain view, CA) as per manufacturer’s
recommendations. Pellets were resuspended in ice cold DMEM, aliquoted, and
frozen at −80°C till use.

Cell and Whole brain lysates - HEK293T cells were lysed 48h post transfection
by incubating cells for 30min in ice-cold lysis buffer containing (in mM): 50 Tris
base, 150 NaCl, 1 EDTA, 1% Triton X-100 and 1x protease inhibitor cocktail
(Thermo Fisher Scientific), pH 7.4. Whole brain homogenate was prepared by
harvesting mouse brains from P0 pups and subjecting them to a brief ice-cold PBS
wash. Brains were then homogenized by sonication (5 x 10sec) in ice cold lysis
buffer using a sonic dismembrator (Fisher Scientific, model F60) with output power
set at 1. Protein amounts in the supernatant was quantified using the BCA assay
(Thermo Fisher Scientific) and was aliquoted and frozen at -80°C until use after
cold centrifugation at 10,000 x g for 15 min.

Co-immunoprecipitation - For AMPAR co-immunoprecipitation 2mg total protein
was incubated with 4µg of either mouse anti-GluA1 (Clone RH95; Millipore,
Billerica, MA), mouse anti-GluA2 (Clone 6C4; Millipore), or control mouse IgG1
(Clone G3A1; Cell Signaling technology, Danvers, MA) antibodies overnight at
4 °C, with gentle rocking. Immune complexes were precipitated for 2h at 4°C using
20µl protein A/G agarose beads (Santa Cruz Biotechnology). For NSG2-mC coimmunoprecipitation, 1.5mg total protein was incubated with either 50µl anti-RFP
mAb-agarose (MBL intl. corp., Woburn, MA) or RFP-Trap_M (ChromoTek Inc.,
Hauppauge, NY) according to manufacturer’s instructions. Agarose beads from
the above reactions were washed and denatured in 50µl 1% SDS and 20µl was
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loaded on an SDS-PAGE gel for Western Blotting or 2µl of the supernatant was
subject to capillary electrophoresis.

Western Blotting and Capillary Electrophoresis - SDS denatured proteins were
processed via SDS-PAGE and transferred to FL-PVDF membranes (Li-COR,
Lincoln, NE) for traditional immunoblotting. For Western blotting primary antibodies
used were rabbit anti-NSG2 (1:500; Abcam, Cambridge, MA), mouse anti-betaactin (1:5000; Clone AC-15; Thermo Fisher Scientific) and mouse anti-GAPDH
(1:500; Clone 6C5; Thermo Fisher Scientific). Secondary antibodies used for
detection of primary antibodies were goat anti-mouse 800CW (1:15,000; LiCOR)
and goat anti-rabbit 680RD (1:15,000; LiCOR) and blots were scanned using the
Odyssey infrared imager and acquired on the Image Studio Lite software suite
(Version 3.1, LiCOR). Capillary electrophoresis was performed on the fully
automated Wes

system

(ProteinSimple,

San

Jose,

CA)

following

the

manufacturer’s recommendations. Briefly, 0.5µg protein lysate (Input lanes) or 2µl
protein (IP lanes) were mixed with 2µl of the 5x Master mix containing SDS and
DTT. The samples and protein standard were boiled at 95°C for 5min. The samples
were dispensed into microplates containing blocking buffer, primary and
secondary antibody and wash buffer in independent wells for sequential
processing. The plate was briefly spun and loaded into the instrument for
electrophoretic separation of proteins in capillary tubes containing a 12-250kDa
separation matrix. The chemiluminescence based electrophoretogram was auto
generated and digitally-rendered bands shown in Figure 4 were generated from
the chemiluminescent peaks using the Compass software (ProteinSimple). For the
Wes, primary antibodies were rabbit anti-NSG2 (1:300), mouse anti-GluA1 (1:100)
and mouse anti-GluA2 (1:50). HRP-conjugated secondary anti-mouse and antirabbit antibodies were used at the predefined concentrations provided by the
manufacturer.
T7 Endonuclease I assay – Neuro-2a cells were transfected with either the
control or CRISPR NSG2 KO gRNA plasmids and allowed to express the
27

constructs for 48-60h. The cells were then harvested and a purified GFP + cells
population was obtained by flow cytometry. The genomic DNA from the GFP+ cell
population was extracted using a commercially available kit (Zymo Research,
Irvine, CA). 100ng of genomic DNA was used as a template for PCR amplification
of a fragment surrounding the putative gRNA cleavage site using the following
primer

pair:

Fwd

5’-TCCCCGGACAATGGGAATCATG-3’

and

Rev

5’-

GTGGCTGGAAGAATGAAAGGAT-3’. Amplicons were then subjected to a single
cycle of denaturation and renaturation to generate heteroduplex molecules
containing mismatches which could be recognized and cleaved using the T7
endonuclease I enzyme (New England Biolabs, Ipswich, MA). The products of the
reaction were resolved on a 2% agarose gel containing 1x gel red stain (Biotium,
Fremont, CA) and imaged on a gel documentation system (Biorad, Hercules, CA).
The relative band intensities of the cut fragments to the uncut fragment were used
to calculate the gRNA-mediated cleavage efficiency.
Immunocytochemistry –

Neurons on coverslips

were fixed with 4%

paraformaldehyde/4% sucrose for 15min, rinsed 3 times for 5min in phosphatebuffered saline (PBS; Sigma), and permeabilized using 0.2% Triton for 10min
(except when staining for surface GluA1 and GluA2). Cells were blocked with 10%
donkey serum in PBS for 1h, followed by an overnight incubation of primary
antibody in 5% donkey serum at 4°C. Primary antibodies consisted of rabbit antiNSG2 (1:500; Abcam), goat anti-NSG1 (1:400; Everest Biotech, Oxford, UK),
mouse anti-GFAP (1:1000; Neuromab, Davis, CA), chicken anti-βIII-tubulin (1:500;
Millipore), rabbit anti-Homer1 (1:1000; Synaptic Systems, GmbH, Goettingen,
Germany), guinea pig anti-Homer1 (1:200; Synaptic Systems), mouse antiSynapsin-1 (1:2000; Synaptic Systems), chicken anti-MAP2 (1:5000; Biolegend,
San Diego, CA), mouse anti-SMI312 (1:1000; Biolegend), mouse anti-PSD95
(Clone 7E3, 1:100; Thermo Fisher Scientific), and antibodies targeting the
amino(N)-terminus of GluA1 and GluA2 (1:100) (see “coimmunoprecipitation”
section). Following primary antibody incubation cells were washed thrice with PBS
and incubated for 1h with secondary antibody in 5% donkey serum. Conjugated
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secondary antibodies used were: DyLight 488, 550 and 647 (1:1000; Thermo
Fisher Scientific), donkey anti-guinea pig CF555 and goat anti-chicken CF647
(both at 1:500; Sigma). Cells were washed with PBS and then in some cases
treated with DAPI (1:10,000 in PBS; Thermo Fisher Scientific), followed by 3
washes with 1X PBS, and mounted on superfrost slides on Fluoromount-G as an
anti-quenching reagent (Southern Biotech, Birmingham, AL). In our hands the
GluA1 antibody described above did not yield much success with hPSNs.
Therefore, we carried out live staining for surface GluA1 on hPSNs with a custom
developed rabbit anti-GluA1 targeting the extracellular epitope of GluA1 (1:200; a
kind gift from Dr. Matthew Kennedy, UC Denver). The cells were incubated live
with the antibody for 15min before three brief PBS washes and fixation with 4%
PFA. The post fixation treatments and secondary antibody incubations were same
as described above.

Confocal Imaging and Analysis - Confocal z-stacks were acquired on the Zeiss
LSM800 airyscan confocal microscope using the 63x/1.40NA Oil objective.
Sequential frame acquisition was set to acquire an average of 10 planes per stack
at 16bit and a minimum of 1024x1024 resolution. Channel gain settings were
optimally adjusted to minimize saturation of punctae and were maintained across
experimental groups. Unmodified images were utilized for all analyses and linear
scaling was applied on images only for presentation purposes using Zen Black 2.3
(https://www.zeiss.com/microscopy/us/downloads/zen.html). Fluorescent signal
colocalization on the single planes from a stack and quantification of punctae
number was performed using the colocalization plugin for ImageJ ComDet version
0.3.4 (https://github.com/ekatrukha/ComDet) as previously described (Esteves da
Silva et al., 2015). Punctae integrated fluorescence intensity over area
measurements were performed with ImageJ 1.48v (https://imagej.nih.gov/ij/). For
each experimental group an average of greater than 200µm dendrite was
quantified for 8 to 10 images per experiment and repeated for a total of three
biological replicates.

29

Electrophysiology - Whole cell patch-clamp recordings were performed a
previously described (Weick et al., 2013) with minor modifications. The
extracellular solution was a modified Hanks’ balanced salt solution (HBSS) that
contained (in mM): 140 NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 15 HEPES, and 23 glucose,
pH 7.4, 300 mOsm. Recording pipettes with resistances of 3 to 5 MΩ were filled
with an intracellular recording solution containing the following (in mM): 121 Kgluconate, 20 KCl, 2 MgCl2, 10 EGTA, 10 HEPES acid, 2 Mg2+-ATP, 0.2 Na+-GTP,
pH 7.2, 290 mOsm. Pharmacological antagonists picrotoxin (50μM; Tocris, Bristol,
UK), TTX (1μM; Tocris), and AP5 (25μM; Sigma) were bath applied in the external
solution. Each experiment consisted of 10 to 13 cells per group and experiments
were repeated three times on different cultures at the same time points indicated
in the results. Neurons were visualized using an Olympus Optical BX51WI
microscope (Olympus Corp., Tokyo, Japan) with differential interference contrast
optics at 40x. Recordings were obtained using a MultiClamp 700B amplifier
(Molecular Devices, Sunnyvale, CA), filtered at 4 kHz and sampled at 100 kHz
using a Digidata 1322A analog-to-digital converter (Molecular Devices). Wholecell capacitance was fully compensated but series resistance was not
compensated. Access resistance was monitored before and after recordings, and
cells with resistances greater than 20 MΩ at either point were discarded from
analyses. Miniature excitatory postsynaptic currents (mEPSCs) were measured
using a holding potential of -70mV while outward potassium currents were elicited
by a voltage-step protocol from -50mV to +50mV, and all recordings were
performed at 32°C. Step protocols were used to verify the lack of inward sodium
current in all cells used for subsequent analysis. Data were stored on a computer
hard disk and postsynaptic currents (PSCs) were analyzed using MiniAnalysis
software (Synaptosoft, Fort Lee, NJ) while potassium currents were analyzed
using Clampfit v. 10.0 (Molecular devices). The cells utilized for mEPSC recordings
for NSG2 knockout (control GFP and CRISPR NSG2 KO) were injected with
Lucifer yellow (10mM; Thermo Fisher Scientific) included in the internal solution.
After recordings cells were immediately fixed and stained for NSG2 as described
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above (see methods; immunocytochemistry). Only cells showing a lack of NSG2
(indicating NSG2 KO) were included for subsequent analysis.

Statistical Analysis - Student's t-tests were used to determine whether mean
differences between groups (e.g., control mCherry vs. NSG2-mC) were significant
and were considered significant a priori if p < 0.05. The number of samples used
for statistical analyses (n) refers to the number of cells assayed per group
accumulated from three independent biological replicates for all imaging-based
assays and electrophysiology experiments. For analysis of synaptic and NSG2
punctae, n’s are still reported by the criteria above but at least 1500 total punctae
were included across cells/replicates. Data are reported as Mean ± Standard Error
of Mean (S.E.M).

Results:
NSG2 is localized to postsynaptic densities of excitatory
synapses
NSG2 is one of the most highly upregulated and abundant mRNAs during
early neuronal development across multiple species, including human (Kang et al.,
2011; Miller et al., 2014; Barford et al., 2017; Murillo et al., 2017). To determine
whether NSG2 protein was similarly upregulated, we first used differentiation of
cortical neurons derived from human pluripotent stem cells (hPSCs) and assayed
for NSG2 using an antibody previously shown to detect the rodent protein (Barford
et al., 2017). Robust NSG2 expression was observed in 98% of the β III-Tubulin+
neurons analyzed (n=151/154 neurons from 5 independent experiments) at days
30 and 50 in culture (Figure 2-1, A-B). These timepoints correspond to periods
prior to and following the formation of functional synapses in hPSC-derived
neurons (hPSNs) (Refer to Figures in Appendix A-D), respectively. NSG2 was not
found in neuroepithelial cells at Day30 that were PAX6+/MAP2- (Figure 2-1, C),
suggesting its upregulation following the final mitotic division. Similarly, NSG2 was
detected by 4 days in vitro (DIV4) in cultured mouse hippocampal neurons (Figure
2A), an early timepoint prior to the creation of functional synapses (Grabrucker et
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al., 2009). NSG2 remained robustly expressed in all hippocampal neurons
examined (n=391/391; from six independent cultures) at all time points assayed
up to DIV30 (Figure 2-2). Similar to previous reports, NSG2 was found robustly
aggregated in perinuclear regions consistent with localization to the Golgi
apparatus (Saberan-Djoneidi et al., 1995) as well as in distinct punctae throughout
βIII-tubulin+ neurites (Figure 2A and yellow box magnified in Figure 2B, blue;
arrows; Figure 2-1). At DIV4, NSG2 was absent from GFAP+ astrocytes in regions
that did not have overlapping βIII-tubulin+ neurites (Figure 2A and yellow box
magnified in Figure 2B, cyan; arrowheads). This was also evident in cultures of
human neurons and glia at Day50 (Figure 2-3, A), supporting the neuron-specific
nature of NSG2 across species. At DIV14 in mouse neurons, the number of NSG2
punctae were dramatically increased as neuronal arbors became more elaborate
(Figure 2C). At this time point, NSG2 punctae were restricted to the
somatodendritic compartment as MAP2+ dendrites showed robust staining (Figure
2C and yellow box magnified in Figure 2D, Figure 2-3, B, blue; arrows) whereas
SMI-312+ axons were devoid of NSG2 (Figure 2C and yellow box magnified in 1D,
Figure 2-3, B, cyan; arrowheads). Together, these data support the neuron-specific
nature of NSG2 and show its punctate localization restricted to somatodendritic
arbors of human and mouse neurons. In contrast to previous reports suggesting
that NSG2 protein is nearly absent in brain following early postnatal development
(Saberan-Djoneidi et al., 1995), Barford et al. recently showed that expression of
NSG2 was maintained in cortex up to the period of adolescence (P16) but was
absent from cerebellum in adults (P60; (Barford et al., 2017)).
Due to sequence homology between NSG family members we determined
whether the antibody used for immunostaining was specific for NSG2. Western
blot analysis was used to validate the specificity of the NSG2 antibody, which
revealed a band of approximately 47kDa in lysates taken from HEK293T cells
overexpressing NSG2 (19kDa) linked to the mCherry (28kDa) fluorophore (NSG2mC; Figure 2E, upper panel, middle lane). However, no bands were detected in
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Figure 2 (Also Figure 2-1, 2-2 and 2-3): A subset of NSG2 punctae localize to postsynaptic
densities of excitatory synapses. (A) Representative confocal images of primary hippocampal
neurons (DIV4) illustrate a perinuclear as well as punctate NSG2 expression pattern (magenta;
arrows) in βIII-Tubulin+ neurons (blue). No NSG2 expression was observed in GFAP + astrocytes
(cyan; arrowheads). The punctate expression pattern of NSG2 was found in all neurons tested up
to DIV30 (Figure 2-1). (B) magnified image of yellow box in the Merge panel of A. (C)
Immunofluorescent images illustrate NSG2 (magenta; arrows) punctae exclusively in MAP2 + (blue)
dendrites and absence of NSG2 punctae in SMI312+ axons (cyan; arrowheads) at DIV14. (D)
magnified image of yellow box in the Merge panel of C. (E) Representative western blot image
demonstrating the specificity of the NSG2 antibody in detecting NSG2 (NSG2-mC; top panel,
~48kDa band; middle lane) but not the closely-related protein NSG1 (NSG1-GFP; top panel,
~48kDa). Bottom panel shows the β-actin loading control. (F) Representative western blot image
demonstrating the expression profile of the NSG2 from mouse whole brain lysate during
development (top panel, ~19kDa band). While GAPDH was used as a loading control (middle
panel) it shows variability across development. The blot was also stained with Coomassie (bottom
panel) to demonstrate equal protein loading. (G) Confocal images showing endogenous NSG2 (left
panels) and overexpressed NSG2-mC (right panels) colocalized with HOMER1+ punctae
(arrowheads; HOMER1 panel and Merge). Endogenous NSG2 and NSG2-mC were frequently
found adjacent to Synapsin1+ punctae (e.g. leftmost arrowheads). Individual panels for HOMER1 +
(white) and SYN1+ (cyan) are shown for clarity. The colocalization profile of NSG2 or NSG2-mC
(magenta trace) with HOMER1 (white trace) for the indicated punctae are indicated in the bottom
panels. Some NSG2 punctae were not found colocalized to either HOMER1 or SYN1 punctae
(arrow). (H) Quantification of colocalization of Homer1 with either endogenous NSG2 or NSG2-mC.
Bars represent mean ± S.E.M for n=10 for each group; *p=0.024. Scale bar represents 10µm (AB), 2µm (B, D and G; left panels) or 4µm (G; right panels).
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Figure 2-1 (Supports Figure 2): NSG2 is robustly expressed in human pluripotent stem cellderived neurons (hPSNs). (A) Representative confocal immunofluorescence images of Day30
hPSNs showing the expression and distribution of NSG2 (magenta; arrows) in βIII-Tubulin+ neurons
(cyan). DAPI+ nuclei are indicated in white. (B) Representative confocal images of Day50 hPSNs
showing the expression and distribution of NSG2 (magenta; arrows) in βIII-Tubulin+ neurons (cyan).
DAPI+ nuclei are indicated in white. (C) Representative confocal images of hPSNs illustrate NSG2
(magenta; arrows) expression restricted to MAP2+ (blue) neurons and absent from Pax6+ neural
progenitors in Day30 hPSN cultures. Nuclear Pax6+ (cyan; arrowheads) colocalized with DAPI+
nuclei (white; arrowheads). Scale bars represent 10μm.
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Figure 2-2 (Supports Figure 2): NSG2 remains expressed in mouse hippocampal neurons at
DIV30. Representative confocal immunofluorescence images of primary hippocampal neurons
(DIV30) showing the expression and distribution of NSG2 (magenta; arrow) in βIII-Tubulin+ neurons
(cyan). DAPI+ nuclei are indicated in white. Scale bars represent 5μm.

Figure 2-3 (Supports Figure 2): NSG2 expression in hPSNs is neuron-specific and
somatodendritic. (A) Representative confocal images of hPSNs illustrate NSG2 expression is
perinuclear (magenta; arrows) and localized to punctae distributed in MAP2+ (blue) dendrites;
NSG2 punctae are absent in GFAP+ astrocytic processes (cyan; arrowheads) at Day50. Far right
panel shows magnified image of yellow box in ‘Merge’. (B) Representative confocal images of
hPSNs illustrate NSG2 punctae (magenta; arrows) exclusively in MAP2 + (blue) dendrites but
absent from SMI312+ axons (cyan; arrowheads) at Day50. Far right panel shows magnified image
of yellow box in ‘Merge’. DAPI+ nuclei are indicated in white. Scale bars represent 10μm.
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lysates taken from HEK293T cells overexpressing NSG1 (21kDa) linked to GFP
(27kDa; Figure 2E, upper panel, right lane) or untransfected HEK293T cell lysates
(Figure 2E, upper panel, left lane). β-actin served as a loading control (Figure 2E,
lower panel). Further, to determine the expression profile of endogenous NSG2
protein over time we performed western blot of mouse whole brain lysates. We
found that while NSG2 has its greatest expression during the perinatal period and
is gradually downregulated thereafter, it continues to be expressed even in adult
animals (P60; Figure 2F) consistent with recent studies (Barford et al., 2017).
Due to the punctate nature of NSG2 expression in dendrites, we determined
whether NSG2 localized to synapses. In DIV14-16 hippocampal neurons a portion
of endogenous NSG2 (endo-NSG2) punctae was independent of both presynaptic
Synapsin-1 (SYN1) and post-synaptic HOMER1 (Figure 2G, arrow), whereas
strong synaptic localization was observed for a subset of endo-NSG2 punctae
(Figure 2G, left panels, arrowheads). Quantification of colocalization showed that
approximately 30% of HOMER1 punctae colocalized with NSG2. By comparison,
NSG2 punctae were frequently found adjacent to, but not colocalized with SYN1
punctae (Figure 2G, left arrowhead). In fact, some endo-NSG2 punctae were found
colocalized with HOMER1 that were not adjacent to SYN1 punctae (Figure 2G, left
panels, far right arrowhead). Similar results were found with overexpressed NSG2mC (Figure 2G, right panels), indicating this construct behaves similarly to the
endo-NSG2 protein. Interestingly, the percentage of HOMER1 punctae that
colocalized with NSG2-mC was significantly increased compared to that for endoNSG2 (Figure 2H; endo-NSG2: 29.2% ± 2.5; NSG2-mC: 37.0% ± 2.0; *p = 0.024).
This happened despite the fact that the total densities of HOMER1 punctae for
control and NSG2-mC were not significantly different (mCherry: 126 ± 7
punctae/100µm; NSG2-mC: 133 ± 10 punctae/100µm; p = 0.6). Thus, the
increased colocalization between NSG2-mC and HOMER1 is likely a result of
NSG2-mC entering HOMER1+ synapses that are not occupied by endo-NSG2.
Taken together these data suggest that NSG2 is present in a subset of excitatory
synapses, and is likely restricted to the postsynaptic density rather than
presynaptic terminals. Furthermore, overexpressed NSG2-mC was not sufficient
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to drive formation of new HOMER1+ PSDs, but was able to enter new sites where
endo-NSG2 was likely absent.

NSG2 interacts with AMPAR subunits GluA1 and GluA2
To determine whether NSG2 colocalizes with functional AMPAR-containing
synapses, we used surface labeling with antibodies directed toward the
extracellular N-termini of the GluA1 and GluA2 subunits. Figure 3A-B shows
representative confocal images of neurons (left panels) as well as individual
neurites (right panels) from boxed regions. Results for both GluA1 and GluA2
revealed robust colocalization with individual NSG2 punctae (Figure 3A-B, right
panel arrowheads). Pooled data revealed that approximately 40% of NSG2
punctae colocalized with either the GluA1 (Figure 3A, C; NSG2/GluA1: 40.1% ±
1.6) or GluA2 subunits (Figure 3B, D; NSG2/GluA2: 41.0% ± 1.5). Reciprocally,
over 45% of GluA1 and GluA2 surface labeled punctae colocalized with NSG2,
suggesting that nearly half of all AMPAR-containing postsynaptic densities
contained NSG2 protein at DIV15 (Figure 3C-D; GluA1/NSG2: 46.2% ± 1.2;
GluA2/NSG2: 48.0% ± 0.9). It is noteworthy that the percent of colocalization
between AMPAR subunits and NSG2 was slightly greater than that of
HOMER1/NSG2, indicating that NSG2 is somewhat selective for AMPARcontaining PSDs. We additionally verified that overexpressed NSG2-mC
colocalized with human GluA1 subunits in hPSNs at Day50. While these data
revealed significant colocalization of NSG2 with surface GluA1 in hPSNs (Figure
3-1), the inconsistent maturational state of individual hPSNs (Johnson et al., 2007)
makes characterization of NSG2 function more difficult. Thus, all future
experiments were conducted on cultured mouse hippocampal neurons.
We next determined whether NSG2 physically associates with AMPAR
subunits GluA1 and GluA2. We first performed co-immunoprecipitation (Co-IP)
from HEK293T cells co-expressing the fusion proteins NSG2-mC (approx. 45kDa)
and either YFP-GluA1 or GFP-GluA2 (approx. 128kDa and 125kDa, respectively).
Using an anti-mCherry monoclonal antibody we immunoprecipitated NSG2-mC
and probed for YFP-GluA1 and GFP-GluA2 using antibodies specific for each
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Figure 3 (Also Figure 3-1): NSG2 colocalizes with AMPAR subunits GluA1 and GluA2. (A-B)
Representative confocal images of primary hippocampal neurons at DIV15 showing perinuclear
and punctate NSG2 (magenta) in MAP2+ (blue) neurites along with surface expressed GluA1
punctae (A, cyan), and GluA2 punctae (B, cyan). Separated color panels for individual markers
from the boxed regions have been magnified for clarity (right panels). Lower right panels in A-B
show the colocalization profile for NSG2 (magenta)/GluA1 (cyan, panel A) and NSG2
(magenta)/GluA2 (cyan, panel B) across the indicated punctae (arrowheads). (C-D) Quantification
of colocalization for NSG2 with surface GluA1 punctae (6423 NSG2 and 5392 GluA1 puncta from
10 neurons) and NSG2 with surface GluA2 punctae (6874 NSG2 and 5963 GluA2 puncta from 9
neurons) respectively from 3 independent cultures. Scale bars represent 10µm (A, B; left panels)
and 2µm (A, B; right panels).

subunit. Figure 4A shows data from a capillary immunoelectrophoresis that
demonstrates NSG2-mC was able to Co-IP both GluA1 and GluA2 independently
(lanes marked IP: mCherry) when the two proteins were co-expressed in HEK293T
cells. An IgG control antibody did not IP either NSG2 or AMPAR subunits
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demonstrating the specificity of the reaction (Figure 4A, IP: IgG); the heavy chain
of the control mouse IgG antibody is detected by the anti-mouse secondary
antibody used to detect GluA1 and 2. To further validate our findings we used the
traditional Co-IP/SDS-PAGE to probe for a NSG2-mC and GluA2 interaction
(Figure 4-1, middle lane). In this case, 24h incubation of lysates taken from

Figure 3-1 (Supports Figure 2): NSG2 colocalizes with AMPAR subunits GluA1 in hPSNs.
Representative confocal images of hPSNs at Day50 overexpressing NSG2-mC showing
perinuclear and punctate NSG2 (magenta) in MAP2+ (blue) dendrites along with surface expressed
GluA1 punctae (cyan). Separate magnified panels for each marker indicated by the boxed region
are provided for clarity (right panels). Colocalized NSG2 punctae (magenta) and surface GluA1
(cyan) are indicated by arrows while non-colocalized proteins are indicated by arrowheads. Scale
bars represent 10µm (left panel) and 2µm (right panels).

HEK293T cells that expressed either protein separately showed significantly
reduced Co-IP, suggesting that their co-expression in a cellular context may be
necessary to drive NSG2-GluA2 interactions (Figure 4-1, right lane). We also
performed

the

complementary

experiment

to

verify

the

interaction

of

overexpressed proteins. Immunoprecipitation of either GluA1 or GluA2 using
antibodies previously described (Schwenk et al., 2014) could Co-IP both
overexpressed NSG2 (Figure 4B, arrow) as well as endogenous NSG2 (Figure 4C,
arrow). In this case we used whole cell lysates from HEK293T cells co-expressing
either GFP-GluA2 or YFP-GluA1 with unlabeled NSG2 (approx. 19kDa) to
demonstrate that non-specific interactions between the fluorophores played no
role in the interactions. In Figure 4B, the lanes marked IP: GluA1 and IP: GluA2
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Figure 4 (Also Figure 4-1): NSG2 interacts with AMPAR subunits GluA1 and GluA2 . (A) CoImmunoprecipication (Co-IP) of overexpressed, fluorophore-conjugated proteins. Representative digitized
western blots from the automated western blot system (see methods) showing that using the anti-RFP
antibody to pull down NSG2-mC (IP: RFP, arrow) could Co-IP both YFP-GluA1 and GFP-GluA2 (IP: mCherry,
arrowhead). A control IgG antibody did not IP nor detect any target proteins (IP: IgG); the heavy chain of
mouse and anti-RFP was detected by the anti-mouse secondary antibody used to detect mouse anti-GluA1/2.
NSG2-mC (arrow), YFP-GluA1 and GFP-GluA2 (arrowhead) were detected in the input (Input). Traditional
western blotting techniques were performed to confirm that GluA2 co-immunoprecipitates with NSG2-mC
(Figure 3-1). Samples were taken from HEK293T cells co-expressing NSG2-mC and either YFP-GluA1 or
GFP-GluA2. (B) Immunoprecipitation of overexpressed, unlabeled NSG2 with fluorophore-conjugated
proteins with antibodies directed toward endogenous protein epitopes. Anti-GluA1 and Anti-GluA2 antibodies
immunoprecipitated YFP-GluA1 and GFP-GluA2 respectively (IP: GluA1 and IP: GluA2, arrowhead).
Unlabeled NSG2 (arrow) coexpressed in HEK293T cells was also detected using these same conditions,
confirming the Co-IP; control IgG did not IP nor detect any target proteins (IP: IgG). NSG2, YFP-GluA1 and
GFP-GluA2 are detected in the input (Input; GluA1; GluA2, arrowhead; NSG2, arrow). Lower bands in NSG2
lanes of control IgG pull down conditions is thought to be non-specific is found in all similar reaction conditions
and migrates faster than NSG2. (C) Immunoprecipitation from in vivo samples (whole brain lysate of P0
mouse). Anti-GluA1 and Anti-GluA2 antibodies immunoprecipitated endogenous GluA1 and GluA2 (IP: GluA1
and IP: GluA2, arrowhead) as well as endogenous NSG2 (arrow). All target proteins were detected in the input
lanes (Input; GluA1 and GluA2, arrowhead; NSG2, arrow). Control mouse IgG antibody did not pull down
GluA1, GluA2, or NSG2 (IP: IgG). As expected, heavy chain and light chains from antibodies used for pull
down were detected in most Co-IP conditions (all “IP” lanes).
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Figure 4-1 (Supports Figure 4): NSG2 and GluA2 physically interact. Representative western
blot image showing Co-IP of NSG2-mC and GluA2 by anti-RFP in lysates from HEK293T cells coexpressing both proteins (Co-IP RFP Trap; NSG2-mC, red bands; GFP-GluA2, green bands). The
specificity of antibodies is confirmed by the absence of bands in lysates from untransfected cells
(Untransfected) and presence of bands of expected size in the input lane (Input-coexpression
lysate). Anti-RFP was unable to Co-IP NSG2-mC GluA2 when the two proteins were overexpressed
in different HEK293T cultures, and lysates were incubated together and then subject to
immunoprecipitation (In vitro incubation).

indicates that both GluA1 and GluA2 were able to Co-IP NSG2 (lower band,
arrow). Finally, we asked whether the interaction between NSG2 and GluA1 and
GluA2 subunits of AMPARs occurs in vivo. Utilizing whole brain protein lysates
from P0 mouse we found that immunoprecipitation of either GluA1 or GluA2
AMPAR subunits pulled down endo-NSG2 (Figure 4C; lanes marked IP: GluA1
and IP: GluA2). Non-specific mouse IgG antibody did not pull down either AMPARs
or NSG2 (Figure 4A, 4B, 4C; lanes marked IP: IgG). Heavy and light chains of
control IgG are present similar to heavy chain in Figures 4A-B; lowest bands in “IP:
IgG” group are likely non-specific as they appear in all groups and are of lower
molecular weight compared to NSG2.

NSG2 expression affects AMPAR currents
Since NSG2 colocalizes with and is found in a complex with AMPAR
subunits GluA1 and GluA2, we next asked if manipulating NSG2 protein levels
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would alter AMPAR surface expression as well as excitatory synaptic transmission.
Two CRISPR/Cas9 guide RNAs (gRNAs) were designed using the MIT CRISPR
design tool to target the mouse NSG2 locus. A T7 endonuclease cleavage assay
determined that both gRNA#1 and gRNA#2 created indels in the NSG2 locus in
mouse Neuro-2a neuroblastoma cells. However, the efficiency (Figure 5-3C) of
gRNA#2 was significantly greater than gRNA#1, so this one was used for all
experiments in primary hippocampal neurons. Transduction of control CRISPR
virus and NSG2 gRNA was performed at DIV4 and neurons were analyzed at
DIV16-18. Figure 5A (upper panels) shows robust NSG2 punctae (arrowheads) in
neurons transduced with control CRISPR lentivirus. In contrast, neurons
transduced with the CRISPR gRNA targeting NSG2 resulted in a complete
knockout of NSG2 (Figure 5A, lower panels; NSG2 KO; arrow). Note that no effect
on NSG2 expression was observed in adjacent, non-transduced neurons (Figure
5A, lower panels, arrowhead). Interestingly, the quantification of NSG2 KO in
neurons transduced with NSG2 CRISPR virus revealed that approximately 70% of
neurons (n=38/55, from 3 independent cultures) had a complete KO. To confirm
specificity of CRISPR targeting, we analyzed NSG1 expression in neurons that
expressed NSG2 gRNA and showed complete KO of NSG2 protein. These
neurons showed no significant difference in the density of NSG1 punctae
compared to neurons expressing control CRISPR constructs (Figure 5-3B; control:
346.3 ± 137.75 punctae/100m; NSG2 KO: 354.3 ± 134.26 punctae/100m; p =
0.97). To determine the effect of NSG2 KO on synaptic transmission we performed
whole-cell patch clamp recordings on GFP+ neurons that received the CRISPRNSG2 KO virus. To eliminate possible contamination from the small proportion of
neurons that did not show NSG2 KO, we used Lucifer Yellow injections followed
by post-hoc analysis of KO efficiency by immunocytochemistry to correlate NSG2
levels with physiological recording data (Figure 5-1; only cells with undetectable
NSG2 signal were used for analysis). Figure 5B shows representative traces of
voltage-clamp recordings from neurons expressing control CRISPR (black) or
NSG2 KO CRISPR virus (green). Compared to control neurons, NSG2 KO
neurons showed a significant decrease in the frequency of miniature excitatory
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Figure 5 (Also Figure 5-1, 5-2 and 5-3): Knockout of NSG2 decreases mEPSC frequency. (A)
Representative confocal images of primary hippocampal neurons at DIV15 showing robust NSG2
(Magenta) in MAP2+ (blue) neurons transduced with control CRISPR GFP lentivirus (cyan; top
panels) whereas neurons transduced with CRISPR KO NSG2 lentivirus (cyan, bottom panels) show
the absence of NSG2 (arrow; bottom panels); NSG2 (magenta) is present in an adjacent neuron
not transduced with the CRISPR KO NSG2 lentivirus in the same field (arrowhead; bottom panels).
(B) Representative traces from whole cell patch clamp recordings from neurons expressing either
control CRISPR GFP (upper trace, black) or CRISPR KO NSG2 (bottom trace, green). Averaged
mEPSCs from both control (black, n=10) and NSG2 KO (green, n=13) are shown to the right. (C)
Pooled data revealed a significant decrease in mEPSC frequency in neurons expressing NSG2 KO
compared to cells expressing control CRISPR GFP (**p = 0.001). The amplitude of mEPSCs was
not significantly different between groups (p = 0.34). Data in the KO group were derived only from
neurons devoid of NSG2 confirmed by post-recording immunostaining of Lucifer yellow injected
neurons (Figure 4-1). NSG2 KO did not alter outward potassium I/V relationship (Figure 4-2). (D)
Quantification of presynaptic marker Synapsin1+ punctae (control, n=10; NSG2 KO, n=10; p =
0.46) and post synaptic marker PSD95+ punctae (control, n=9; NSG2 KO, n=11; p = 0.18). (E)
Representative confocal images illustrate PSD95 immunofluorescence (cyan) in neurons
expressing CRISPR KO NSG2 (right panels) or controls CRISPR GFP (left panels). GFP
expression from both groups (top panels) is presented in grayscale for clarity. Quantification
revealed a significant reduction in PSD95 fluorescence intensity in neurons expressing NSG2 KO
(n=11) compared to controls (n=9; *p = 0.029). (F) Pooled data show that the number of surface
GluA1+ punctae (left; control, n=10 and NSG2 KO, n=9; p = 0.86) and surface GluA2+ punctae
(right; Control, n=10 and NSG2 KO, n=9; p = 0.18) remained unchanged between groups. Bars
represent mean ± S.E.M. Scale bars represent 10µm in (A) and 1µm (E).
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Figure 5-1 (Supports Figure 5): Lucifer Yellow injections used to verify NSG2 KO in recorded
neurons. Representative confocal images of primary hippocampal neurons (DIV15) showing the
absence of NSG2 (magenta, arrow) in MAP2+ neurons (blue) transduced with CRISPR KO-NSG2
lentivirus (cyan). Lucifer Yellow was injected into neurons expressing CRISPR KO-NSG2 during
whole cell patch clamp experiments (Inset: Luc. Yellow; Figure 4). NSG2 (magenta) was present
in MAP2+ neurons not expressing CRISPR KO-NSG2 (arrowhead). Scale bars represent 10μm.

Figure 5-2 (Supports Figure 5): Alterations in NSG2 levels does not affect voltage-gated
potassium currents. (A-B) Current-voltage relationship plots illustrating that neither NSG2-KO (A,
open circles) nor NSG2-mC overexpression (B, open circles) caused a significant change to
transient potassium current elicited by voltage steps compared to controls (A-B, black squares).
(C-D) Representative traces from plots in panels A-B in response to voltage steps from -50mV to
+50mV (step size, 10mV).
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Figure 5-3 (Supports Figure 5): Knockout of NSG2 does not alter NSG1 levels. (A)
Representative confocal images of primary hippocampal neurons (DIV15) showing the presence
of NSG1 (white, arrowhead) in MAP2+ (blue) neurons from GFP+ cells transduced with either
CRISPR control (cyan; top panels) or CRISPR KO-NSG2 lentivirus (cyan; bottom panels). Middle
panels illustrate the presence of NSG2 (magenta, arrow) in MAP2+ neurons (blue) transduced with
CRISPR control (top panels) and absence of NSG2 (arrow) in MAP2 + neurons (blue) transduced
with CRISPR KO-NSG2 lentivirus (cyan). Scale bars represent 10µm. (B) Pooled data show that
the density of NSG1 punctae remained unchanged between groups (Bars represent mean ± S.E.M,
n=10 per group; p = 0.97). (C) Representative agarose gel showing digested fragments from mouse
NSG2 DNA amplicon (arrow) were observed in cells that received either gRNA#1 or gRNA#2 + T7,
but not in control or without T7.
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postsynaptic currents (mEPSCs), with no change in amplitude (Figure 4B-C;
Frequency; control: 12.41 ± 2.31 Hz; NSG2 KO: 4.07 ± 0.68 Hz; **p = 0.001;
Amplitude; control: 16.71 ± 4.10 pA; NSG2 KO: 15.84 ± 4.47 pA; p = 0.34). These
effects were specific to synaptic currents as voltage-gated potassium currents
remained unchanged (Figure 5-2). To probe the mechanism of how NSG2 might
affect mEPSCs, we performed immunocytochemical labeling of multiple synaptic
proteins. NSG2 KO did not affect the density of presynaptic SYN1 + nor
postsynaptic PSD95+ punctae along neurites (Figure 5D; SYN1; control: 93 ± 8
punctae/100μm; NSG2 KO: 79 ± 7 punctae/100μm; p = 0.46; PSD95; control: 97
± 7 punctae/100μm; NSG2 KO: 80 ± 9 punctae/100μm; p = 0.18). Interestingly, the
fluorescence intensity of PSD95+ punctae was significantly decreased in NSG2
KO neurons compared to controls (Figure 5E; control: 3.70 ± 0.45 A.U.; NSG2 KO:
2.57 ± 0.28 A.U.; *p = 0.04). This occurred without a corresponding change in the
density of GluA1- and GluA2-containing punctae along neurites (Figure 4F; surface
GluA1+; control: 86 ± 8 punctae/100μm; NSG2 KO: 83 ± 12 punctae/100μm; p =
0.86 and surface GluA2+; control: 94 ± 7 punctae/100μm; NSG2 KO: 74 ± 12
punctae/100μm; p = 0.18). Together, these data indicate that the reduction in
mEPSC frequency due to loss of NSG2 may be caused by a relatively subtle effect
on postsynaptic scaffolding rather than a failure of AMPAR exocytosis.
To test whether NSG2 can augment postsynaptic targeting of AMPARs we
used overexpression of NSG2-mC, which shows nearly identical synaptic targeting
as endo-NSG2 (Figure 2D). Figure 6A shows representative traces of voltageclamp recordings from neurons overexpressing mCherry (black) alone or NSG2mC (red). Pooled data revealed that neurons expressing NSG2-mC showed a
significant increase in mEPSC amplitude compared to those expressing mCherry
alone (Figure 6A, B; mCherry: 21.61 ± 1.43 pA; NSG2-mC: 30.22 ± 3.07 pA; **p =
0.01). In contrast to NSG2 KO, no significant difference was observed for mEPSC
frequency upon NSG2 overexpression (Figure 6B; mCherry: 12.88 ± 2.91 Hz;
NSG-mC: 17.66 ± 4.12 Hz; p = 0.35). Immunocytochemical analyses revealed that
the intensity of GluA1 and GluA2 staining showed a trend toward an increase but
that did not reach significance (Figure 6C, E; Fluorescence Intensity of GluA1;
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mCherry: 1.00 ± 0.38 A.U.; NSG2-mC: 1.63 ± 0.54 A.U.; p = 0.36 and GluA2;
mCherry: 1.00 ± 0.11 A.U.; NSG2-mC: 1.32 ± 0.21 A.U.; p = 0.19). Interestingly,
while the number of surface GluA1+ punctae remained unchanged (Figure 6C;
mCherry: 92 ± 10 punctae/100μm; NSG2-mC: 97 ± 8 punctae/100μm; p = 0.58),
the number of GluA2+ punctae was significantly increased upon NSG2-mC
overexpression (Figure 6E; mCherry: 94 ± 6 punctae/100μm; NSG2-mC: 123 ± 10
punctae/100μm; *p = 0.02). These data suggest that NSG2 is sufficient to drive
increased surface expression of AMPARs into existing functional synapses, and
potentially to a small proportion of previously silent synapses.

Figure 6: Overexpression of NSG2 increases mEPSC amplitude. (A) Representative traces
from whole cell patch clamp recordings from neurons expressing either mCherry alone (upper
trace, black) or NSG2-mC (bottom trace, red). Averaged mEPSCs from both control (black, n=11)
and NSG2-mC (red, n=10) are shown to the right. (B) Pooled data illustrate that neurons expressing
NSG2-mC showed a significant increase in mEPSC amplitude compared to controls (**p = 0.01)
whereas the frequency of mEPSCs was not different between groups (p = 0.35). (C) Neither GluA1 +
punctae number (p = 0.58) nor Relative Fluorescence Intensity (p = 0.36) were significantly different
between groups (mCherry vs NSG2-mC). (D) Representative confocal images showing neurons
expressing either mCherry alone (left panels) or NSG2-mC (right panels) stained for MAP2
(magenta) and surface GluA2 (cyan). Individual GluA2 and MAP2 expression from both groups
(top two panels) are presented in grayscale for clarity. (E) Pooled data revealed the number of
GluA2+ punctae was significantly increased in neurons expressing NSG2-mC (n=10) compared to
controls (n=10; *p = 0.02) while Relative Fluorescence Intensity remained unchanged (p = 0.19).
Bars represent mean ± S.E.M; A.U. = Arbitrary units. Scale bars represent 2 µm.
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Conclusion and Discussion
While critical roles in endosomal trafficking and synaptic plasticity have
been established for NSG1 and NSG3, no functional role for NSG2 has previously
been demonstrated. Here we present evidence that NSG2 is a novel modulator of
excitatory synaptic function. We found NSG2 displays a punctate pattern of
expression that is restricted from axons but found robustly throughout
somatodendritic arbors. Approximately forty percent of all postsynaptic densities
that contained surface expressed AMPAR subunits also displayed colocalized
NSG2 punctae. Reciprocal immunoprecipitation assays revealed that NSG2
interacts with both GluA1 and GluA2 AMPAR subunits in vitro and in vivo.
CRISPR/Cas9-mediated knockout of NSG2 in primary hippocampal neurons
resulted in a significantly reduced frequency of AMPAR-mediated mEPSCs, in the
absence of a reduction in total surface expressed AMPAR levels. Surprisingly,
overexpression of NSG2 caused a significant increase in the amplitude of AMPARmediated mEPSCs that was coincident with increased surface expression of the
AMPAR subunit GluA2, but did not affect frequency as in the knock out condition.
Together, these data suggest NSG2 is a novel player in excitatory postsynaptic
function potentially via trafficking of AMPAR and/or associated cargo proteins (see
below and Figure 7).
While it remains unclear as to how NSG2 modulates excitatory synaptic
function specifically, the preponderance of evidence points to the regulation of
AMPAR surface expression via secretory trafficking. This is supported by our
current findings in conjunction with a number of findings for other NSG family
members. For instance, NSG3 facilitates clathrin-mediated endocytosis of
AMPARs during agonist stimulated activity that causes synaptic depression (Xiao
et al., 2006b; Davidson et al., 2009b). Overexpression of NSG3 was shown to
cause internalization of GluA1 and GluA2, decreasing surface expression levels of
AMPARs. Furthermore, chronic upregulation of NSG3 in a transgenic mice was
shown to impair executive cognitive function (Xiao et al., 2006b; Kruusmägi et al.,
2007; Davidson et al., 2009b; Vazdarjanova et al., 2011), likely via alterations in
AMPAR trafficking and altered long-term depression like processes
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Figure 7: Summary of important findings from Chapter 2. (A) NSG2 (cyan) localizes as distinct
punctae at or near postsynaptic regions in what are presumed to be vesicular compartments. NSG2
interacts with AMPARs (dark blue/red) and helps deliver them to the surface of the cell either within
dendritic spines (upper left), or in perisynaptic regions (lower right). (B) AMPAR surface delivery is
revealed via average AMPA mEPSCs under basal conditions (left) which significantly increases
upon NSG2 overexpression (right).

(Myers et al., 2006; Kim et al., 2007). In contrast, NSG1 has been shown to
regulate the rate of AMPAR receptor recycling within the post-synaptic density
(Steiner et al., 2005b; Utvik et al., 2009). While no studies report the functional
consequences of full-length NSG1 overexpression, inhibition of NSG1 function via
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a dominant negative peptide prevented constitutive recycling of GluA1/2containing AMPARs following NMDA-mediated internalization (Alberi et al., 2005b;
Steiner et al., 2005a). Similarly, antisense-mediated suppression of NSG1 function
severely impaired the amplitude of evoked potentials in organotypic hippocampal
slices (Alberi et al., 2005a). However, it is not clear whether the observed effect on
amplitude was a consequence of a reduction in the number of AMPARs within
individual synapses, or a reduction in the number of synapses that contained
AMPARs. For example, Levy et al., demonstrate that the effect of changing levels
of the MAGUK family of scaffolding proteins, specifically knockdown of PSD95
causes a reduction in AMPAR mEPSC frequency in dissociated hippocampal
neurons by increasing the number of silent synapses, however without affecting
mEPSC amplitudes (Levy et al., 2015). Thus, one explanation for our observations
could be that in NSG2 KO neurons, a subset of synapses that would have
contained NSG2 showed reduced or altered AMPAR localization that our methods
were not sensitive enough to detect via immunocytochemistry. In this case, these
synapses demonstrated increased failure rates or sub-threshold events which
resulted in a decrease in mEPSC frequency. However, the absence of an effect
on AMPAR surface expression suggests either subtle changes in AMPAR
localization or an alternate mechanism. We cannot rule out a role of NSG2 on
presynaptic function, although manipulation of NSG1 and NSG3 does not alter
presynaptic release (Alberi et al., 2005; Davidson et al., 2009), and NSG2 is solely
found in the post-synaptic density (Figures 2 and 3). While future studies are
needed to elucidate the mechanistic details of how NSG2 is involved in regulating
AMPAR trafficking, our data support a complementary role of NSG2 with that other
NSG family members.
One mechanism likely involves secretion of AMPARs via Post-Golgi
endosomal vesicles that may contain individual or combinations of NSG family
members depending on function. NSG2 was originally proposed to have a role in
secretory trafficking for the following reasons: 1) it is a single-pass transmembrane
protein enriched in the Golgi apparatus and post-Golgi vesicular compartments, 2)
its presence in the P3 subcellular fraction of whole brain ultracentrifugation and, 3)
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it contains a secretogranin III-like domain in its carboxy-terminus (SaberanDjoneidi et al., 1995). Recent evidence from Yap and colleagues confirmed the
secretory capacity of NSG2. Blocking endocytosis using a dominant negative Rab5
resulted in accumulation of NSG2 on the surface of hippocampal neurons (Yap et
al., 2017). Here, we found that surface GluA2 levels and consequently AMPAR
mEPSC amplitude were significantly increased upon NSG2 overexpression,
suggestive of a link between its role in the secretory pathway and surface AMPAR
levels. It is especially intriguing that NSG2 has an asymmetric synaptic distribution,
being present in approximately forty percent of excitatory synapses. As mentioned,
data from this and previous studies show that inhibiting either NSG1 or NSG2
significantly, but not completely, inhibits synaptic transmission. Thus, it will be
critical to determine whether other NSG family members occupy the same, or
divergent populations of synapses, and whether the effects of their inhibition are
additive. Furthermore, understanding their temporal or activity-dependence will be
critical. For instance, do NSG family members mark specific subsets of synapses,
or do NSG proteins transiently visit most or all synapses during development or
during particular types of activity? Future investigations to answer these questions
should reveal previously unappreciated functional differences between individual
excitatory synapses across multiple brain regions.
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Chapter 3: NSG2 is stably incorporated into a subset of
synapses
Introduction
As mentioned, NSG1 and NSG3 are established regulators of AMPAR
trafficking at PSDs through multiple endo-lysosomal compartments, and have
recently been shown to localize to the plasma membrane (Yap et al., 2017).
Experiments in Chapter 2 discovered that NSG2 is also an AMPAR-binding protein
that regulates network excitability under basal conditions. Most interestingly, static
analysis of NSG2 localization found it in a minority of synapses (30-40%) that
colocalize with surface AMPARs. Assuming that NSG2 exerts the same function
across synapses, the greatest effect of NSG2 KO on mEPSC frequency should be
proportional to the number of synapses that contain NSG2; (i.e. 30-40%).
However, constitutive knockout of NSG2 reduced mEPSCs frequency by greater
than 60% (Chapter 2, Figure 5). This apparent discrepancy is difficult to reconcile
and requires further investigation.
Previously published research describing NSG family member functions
provide some insight into one possible mechanism. Yap and colleagues used
cultured hippocampal neurons at DIV 9 and simultaneously imaged NSG1 and
NSG2 tagged to different fluorescent proteins. They found that both NSG1 and
NSG2 are motile proteins that were trafficked in both antero- and retrograde
directions in dendrites (Yap et al., 2017). Interestingly, they were largely trafficked
together, and quantified data suggested ~60% colocalization. However, this
general finding raises an interesting question about how NSG proteins affect their
function at synapses. It is possible that NSG proteins traffic between synapses to
influence a larger fraction of synapses than their steady state localization would
suggest. Alternatively, NSG2 could be targeted to a minority of synapses that carry
a disproportionate amount of synaptic activity.
Support for both hypotheses can be found in previous studies. In support of
the trafficking hypothesis, previous research has demonstrated the internalization
of AMPARs via EEA+ EEs (Parkinson and Hanley, 2018), recycling of AMPARs
during LTP via RAB4/11+ vesicles (Park et al., 2004; Hoogenraad and van der
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Sluijs, 2010; Esteves da Silva et al., 2015; Hiester et al., 2018), and degradation
via RAB7+ LEs and LAMP1+ lysosomes (Ehlers, 2000). Interestingly, recent
studies have even demonstrated LAMP1+ vesicles are trafficked between
synapses in an activity-dependent manner (Goo et al., 2017; Padamsey et al.,
2017). NSG1 and NSG2 have been found co-localized with several different types
of endolysomal vesicles including EEA1, Rab4/5, Rab7, Rab11, and Lamp1, and
NSG2 localized to ~37% of the synaptic fraction (PSD95+) that also contained
LAMP1 (Figure 8A-B).

Figure 8: Localization of NSG2 in LAMP1+ synapses. (A) Representative MAP2+ (blue, all
panels) dendritic segments from a hippocampal neuron (DIV15) stained for endogenous NSG2
(red, top panel), LAMP1 (white, 2nd panel), PSD95 (green, 3rd panel) and Merge (bottom panel).
White arrowheads point to NSG2 puncta that colocalize with PSD95 only, yellow arrowheads point
to NSG2 puncta that colocalize with LAMP1 only. White arrows point to the localization of NSG2 at
PSDs containing LAMP1 (triple colocalizaton). Scale bars represent 2m. (B) Bar graphs showing
the pooled data of colocalization of NSG2 with either PSD95 or LAMP1 and PSD95/LAMP1
together (N=10 neurons, at least 5 dendrites from each neurons).
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In support of the disproportionate activity-hypothesis, Pak and colleagues
(2013) discovered that homeostatic scaling in hippocampal cultures is not
uniformly distributed across synapses and cells, but primarily driven by changes in
the mossy fiber (MF)-CA3 synapses (Lee et al., 2013). Here we explored these
two hypotheses using a combination of static and timelapse imaging. We also
performed synaptic analysis of NSG2 localization following various types of
stimulation to determine if synaptic localization is dependent on activity.
Surprisingly, our data seem to support the stable incorporation of NSG2 into a
subset of synapses hypothesis, with alterations in activity causing only slight
modifications to NSG2 synaptic localization. Lastly, we performed a cursory
examination of which synapses may preferentially incorporate NSG2.

Materials and Methods
Culture and viral transduction: Primary mouse hippocampal cultures and
lentiviral preparation and transduction were performed essentially as described
previously in Chapter 2. Neurons meant for live cell imaging were cultured on
25mm glass coverslips and maintained in phenol red free Neurobasal media.
pFUW-EFS-PSD95FingR-eGFP was a kind gift from Dr. Don Arnold . For live cell
imaging experiments, lentiviral transductions with both NSG2-mCherry and
PSD95FingR-eGFP were performed on DIV4-5 neurons prior to synaptogenesis
with an MOI of 2-3.

Live cell imaging: Virally transduced neurons at DIV16-18 were transferred into
a custom built coverslip adapter and placed with phenol red free Neurobasal media
into a live imaging environment controlled chamber with a humidified heated stage
maintained at 35°C and 5% CO2. Dual colored live imaging was conducted on an
inverted Zeiss LSM880 confocal microscope using 63X water objective
(Apochromat 1.2 W). Images from the 488 and 561 channels were acquired every
minute for 3h in the sequential bidirectional scan-frame mode with light gate
settings to reduce any overlapping fluorescence spectra. (X,Y,Z) co-ordinates
were established for 2-3 fields of view which were imaged simultaneously during
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a single 3h imaging session from a single coverslip. Imaging was performed from
2-3 coverslips over 3-4 independent cultures.

KCl induction of plasticity: Neuronal cultures for KCl induction experiments were
used at DIV 15-16. Neuronal media was aspirated and replaced with room
temperature Tyrode’s buffer containing (in mM) 128 NaCl, 5 KCl, 1 MgCl2, 2
CaCl2, 4.2 NaHCO3, 20 glucose and 25 HEPES buffer; pH=7.4; mOsm=300) for
5min for neurons to acclimate. This was followed by High K + stimulation by
replacing the regular Tyrode’s buffer with one Tyrode’s containing 50mM K+
(in mM): 78 NaCl, 50 KCl, 1 MgCl2, 2 CaCl2, 4.2 NaHCO3, 20 glucose, and 25
HEPES buffer; pH=7.4; mOsm=300) for 3min. For the 3min timepoint cells were
immediately fixed and for the 10 and 20min timepoints the cells were washed once
with regular Tyrode’s and allowed to incubate in the buffer for 10 or 20min and
subsequently fixed.

Chemical induction of long-term potentiation (cLTP): Glycine-stimulation
dependent cLTP was performed in DIV 15–17 neurons as previously described by
Das and colleagues (Das et al., 2013). Briefly, neurons were incubated at 37°C for
5-10 min in Mg2+ free HBSS solution containing (in mM): 124 NaCl, 2 CaCl2, 3
KCl, 10 HEPES, 10 glucose (pH=7.4; mOSM=300). Activity induction was coupled
with NMDAR saturation with HBSS supplemented with 20 μM bicuculine and 200
μM glycine for 5 min, and finally HBSS supplemented with only 20 μM bicuculine
for 15 min before fixation and imaging.

Immunocytochemistry and Image Analysis: Primary neurons were fixed at
indicated times and/or treatment conditions using 4% PFA/4% sucrose for 10min
and subject to immunostaining as previously described in Chapter 2. Image
analysis with ImageJ was also as previously described in Chapter 2.
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Results
As mentioned, NSG2 is both developmentally regulated (Chapter 2, Figure 2F) as
well as actively trafficked within neurites (Yap et al., 2017). However, Yap et al.
(2017) used rat neurons at DIV9 when synapses are still developing and little
activity is observed (Basarsky et al., 1994). In contrast, most of our studies are
performed in mouse cultures at later timepoints when neurons display more
synaptic activity (e.g. DIV14-21; (Basarsky et al., 1994; Grabrucker et al., 2009)).
Thus, it is critical to determine whether NSG2 was still actively transported at these
timepoints in mouse hippocampal neurons. Figure 9A shows a DIV14 hippocampal
neuron expressing NSG2-mCherry that underwent timelapse imaging to examine
the dynamic movements of NSG2. Figure 9B (boxed region in 9A) illustrates
multiple examples of punctae that moved in the anterograde (magenta) or
retrograde (green) direction, or remained stable throughout the imaging period
(yellow). Binned data illustrate that close to 80% of NSG2-mCherry punctae moved
at rates between 0.2 and 0.6µm/sec, consistent with Kinesin and Dynein-mediated
active transport and NSG3 (Ma and Chisholm, 2002; Shi et al., 2017). Some
punctae were observed moving at rates as high as 4µm/sec, while a minority of
punctae remained stable for the 5 minute imaging session (Figure 9C). Thus, we
conclude that at days when synaptic activity is present in hippocampal cultures,
the vast majority of NSG2 is still actively transported in neuronal dendrites. To
determine whether NSG2 is trafficked between synapses or is relatively stable at
a specific subset, we performed extended timelapse imaging of NSG2-mCh and
PSD95-FingR-eGFP, which marks relatively mature synapses (Gross et al., 2013).
We initially imaged neurons over the course of 3 hours to generate a gross
measure of stability/lability. We noticed that many PSD95-FingR punctae were
unstable during the 3hr period, with 38.3% (n=75) lost while 30.1% (n=59) were
gained throughout the timecourse.
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Figure 9. NSG2-mCherry is actively transported in DIV14 hippocampal neurons. (A) Merged
Differential Interference Contrast (DIC) and Fluorescent images of NSG2-mCherry (red) at the
beginning (left panel) and end (right panel) of a 5 minute time series. (B) Kymograph of boxed
region in A showing NSG2-mCherry puncta (red) along neurites at timepoint 0 (top) and 300
seconds (bottom). Kymograph illustrates dynamic, bidirectional transport of some NSG2-mCherry
punctae as well as a proportion of stationary punctae. (C) Pooled data show that most NSG2mcherry punctae were actively transported at rates >0.3um/sec, while a smaller proportion of
punctae remained stable.
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Figure 10. Timelapse imaging reveals synaptic targeting of NSG2 into a subset of
hippocampal synapses. (A) Fluorescent images of PSD95-FinGR (green) and NSG2-mCherry
(red) at the beginning (upper panels) and end (lower panels) of a 3hr time series. Arrows indicate
stable, co-localized punctae. Arrowheads indicate stable PDS95 punctae alone. (B) Pie chart
illustrating the proportion of stable and transient interactions.

However, a significant proportion of PSD95-FingR punctae remained stable
(n=62, 31.6%), and we quantified those that contained NSG2-mCherry punctae
throughout the imaging session. Figure 10A shows images at the outset (T=0) and
at the end of the imaging session (T=3hr) illustrating that many PSD95-FingR+
synapses were observed that both co-localized with NSG2-mCherry (Figure. 10A,
arrowheads), and that were devoid of NSG2-mCherry (Figure. 10A, arrows).
Pooled data show that the vast majority of the total PSD95-FingR+ synapses that
persisted for the imaging period, 63.9% never showed NSG2-mCherry
colocalization (orange pie; n=291 punctae across 4 cells) while 33.0% showed
stable incorporation of NSG2-mCherry (grey pie). In contrast, a small minority of
synapses gained (2.1%, blue pie) or lost NSG2-mCherry (1%, yellow pie).
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However, several of the punctae in these last two categories appeared to be
transient interactions (n=4/9) lasting only a few frames. It is unknown whether they
represent functional interactions (see discussion).
We next asked whether multiple types of plasticity-inducing stimuli could
direct endogenous NSG2 to AMPAR-containing PSDs, similar to previous studies
of endolysosomal vesicles (Padamsey et al., 2017). First we used the addition of
50mM KCl for 3 minutes to promote neuronal depolarization, a protocol that
triggers robust synaptic activity, and downstream activation of multiple kinase
cascades and CREB activation (Weick et al., 2003; Molnár, 2011). Figure 11A
shows representative images of dendrites from two conditions, unstimulated
controls and cells that received a 3 minute 50mM KCl solution followed by 20 min
incubation period in unstimulated conditions (see methods). Pooled analysis
across multiple conditions demonstrates that 3 minute KCl treatment was sufficient
to increase both the number of surface GluA1 punctae and the number of NSG2
punctae in MAP2+ neuronal dendrites (Figure 11B). Punctae density for both
GluA1 and NSG2 reached significance at the 10min and 20min timepoints
following stimulation, while cells that were fixed immediately following 3min KCl
treatment were not statistically different from controls (Figure 11B). It is intriguing
that the number of NSG2 punctae were significantly increased by this stimulation
as this was not predicted based on previous studies of endolysosomal vesicle
trafficking studies.
Second, we examined whether this stimulation paradigm increased the
number of NSG2 punctae at synapses. To do so we quantified the percent of
surface GluA1 punctae that co-localized with endogenous NSG2 under the same
stimulation conditions. Here we noticed a trend toward an increase co-localization,
with mean increases of 7.8% and 10.2% in the 10min and 20min incubation
groups, respectively (Figure 11C). However, these did not reach statistical
significance of p=0.05, likely due to increased variability upon stimulation.
Furthermore, co-localization in control conditions was somewhat lower than
previously determined, possibly contributing to the appearance of increased
synaptic localization of NSG2 upon KCl stimulation. However, it is critical to note
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that this apparent increase occurs simultaneously with an increase in surface
AMPAR staining, indicating that indeed, at least some new surface GluA1 punctae
must incorporate NSG2. Otherwise, NSG2 co-localization levels would be
expected to decrease when the numbers of sGluA1 punctae increase if NSG2
levels remained unchanged.

Figure 11: KCl promotes AMPAR surface expression and modestly increased synaptic NSG2
localization. (A) Fluorescent images of NSG2 (red, upper panels), surface GluA1 (green middle
panels), and merge with MAP2 (blue, lower panels) in unstimulated conditions (left) and following
3 minute 50mM KCl treatment followed by a 20 minute unstimulated period (right). Arrowheads
indicate co-localized punctae while arrows indicated sGluA1 punctae. (B) Pooled data illustrate the
number of punctae/um of dendrite under multiple conditions (see methods). (C) Pooled data
illustrate the percent of co-localized NSG2 punctae with surface GluA1 punctae under the same
stimulation conditions in B.
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Figure 12: ChemLTP promotes AMPAR surface expression but not increased synaptic NSG2
localization. Representative confocal images of endogenous NSG2 (red, upper panels) and
surface GluA1 (green, middle panels, merge) under unstimulated control conditions (left) or
following cLTP treatment (right). Merge panels (bottom) illustrate colocalized NSG2/GluA1 punctae
(arrowheads) in control untreated (left panels) and glycine induced cLTP consitions (right panels).
Arrows indicate sGluA1 puncta not co-localized with NSG2. (B) Bar graphs illustrating the increase
in number and fluorescence intensity of sGluA1 puncta upon cLTP induction and the colocalization
between NSG2 and sGluA1.

Next we used chemical method to induce long-term potentiation (cLTP) in
cultured neurons (Das et al., 2013). To induce cLTP we treated cells with 200µM
Glycine to promote NMDA receptor activation for 5 minutes, which has previously
been shown to increase both AMPAR surface expression and increased mEPSC
amplitude and frequency (Lu et al., 2001). Figure 12 shows representative confocal
images of dendrites stained for both NSG2 and surface GluA1 under control (left)
and cLTP-inducing conditions (right).Summarized data illustrates that 5min glycine
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treatment significantly increased both the number (left graph) and intensity (middle
graph) of sGluA1 punctae, with magnitudes of approximately two-fold.
Interestingly, similar to experiments using KCl treatment, we observed a trend
toward increased co-localization of NSG2 and sGluA1 punctae, but again this
failed to reach significance. In fact, the greatest proportion of NSG2/GluA1 colocalization observed was similar to that in our published work (~40%; (Chander et
al., 2019)). However, also similar to the conclusions from the KCl experiments, the
slight increase in co-localization accompanied a highly significant increase in
surface AMPARs, suggesting that new synapses did incorporate new NSG2
proteins, despite the fact that the overall proportion remained similar to control
conditions. Future experiments are necessary to determine how and whether
NSG2 is trafficked to existing synapses or new sGluA1 punctae following these
stimulation paradigms.
One major question that arises from these findings is what specific type of
synapses preferentially incorporate NSG2. Aside from our work on NSG2
(Chander et al., 2019), the synaptic localization of NSG proteins is unknown.
However, based on functional properties and observations from immunostaining
(see below) we can make some hypotheses wither regard to their spatial
segregation. While the majority of hippocampal afferents terminate on PSDs that
display similar types of NMDA-dependent forms of postsynaptic plasticity, a major
exception are the Mossy fiber (MF) synapses of the dentate granule cells onto Hilar
and CA3 pyramidal cells. The postsynaptic structure on the CA3 dendrite consists
of elaborate multiheaded spines known as a thorny excrescence (TE) (Amaral and
Dent, 1981). Because of its size and position near the soma of CA3 neurons,
activation of single mossy fiber synapses can cause spiking in CA3 neurons.
Therefore, these are referred to as ‘‘detonator’’ synapses (Urban et al., 2001). This
pathway displays pronounced short-term facilitation and a presynaptic form of
LTP that is independent of NMDAR activation (Zalutsky and Nicoll, 1990; Nicoll
and Schmitz, 2005).
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Figure 13: NSG2 is present in large PSDs. (A) Published data illustrating NSG2 colocalized with
large surface GluA1 aggregates on proximal dendrites (Chander et al., 2019). (B) AF405-filled
neuron (blue) stained for NSG2 (red) shows significant expression in large, multi-headed PSDs
(arrowheads) but is absent from some individual spines (arrows). (C) Proof of concept for in vivo
injections of viral tdTomato expression (red) and labeling of NSG2 (green, arrowheads) in a
hippocampal neuron at P15. Scale bar 10m.
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We hypothesize that NSG2 plays a predominant role in promoting robust
postsynaptic AMPAR surface expression under basal conditions (see Chapter
4), but not plasticity-inducing ones. Interestingly, multi-headed spines are still
formed by cultured CA3 neurons and retain their input-specificity from DG neurons
(Williams et al., 2011). Thus, as an initial examination of whether NSG2 is present
in MF-CA3 neurons we looked for large, multi-headed spines near large cell bodies
in mixed hippocampal cultures (Figure 13B). In support of this we observed a
preponderance of synaptic NSG2 localization occurred at relatively large PSDs on
proximal dendrites (Chapter 2, Figure 3; (Chander et al., 2019) and Figure 13A).
In neurons that displayed complex, multi-head spines on proximal dendrites we
found that many of these contained NSG2 (Figure 13B, arrowhead), suggesting
colocalization with Mossy Fiber synapses. While a previous study showed that
MF-CA3 synapses could be identified by colocalization of synaptoporin and/or
CDH9 with excitatory synaptic markers, we were unable to replicate these
findings. Thus, future studies are necessary to determine whether NSG2 is
selectively incorporated into TEs. Finally, we wanted to know if NSG2 punctae
get incorporated into firstly, dendritic spines and secondly, into TE like synapses
in vivo. For this, we expressed tdTomato in the hippocampal neuron via in vivo
lentiviral injection into P0 newborn mouse brain. Mice brains were harvested two
week after injection and fixed. 30m vibratome sectioned brains were stained
for endogenous NSG2, followed by imaging. NSG2 punctae (Figure 13C, green,
arrowhead) were clearly seen in the tdTomato filled dendritic spines (Figure 13C,
magnification of the boxed region). Future studies will aim to decipher if the
NSG2 punctae also localize in CA3 mossy fiber (TE) synapses.

Conclusion and Discussion:
Here we found that, in contrast to our prediction that NSG2 is trafficked
between synapses to affect neuronal excitability, it appears to be stably
incorporated into a subset of excitatory PSDs. Furthermore, we showed that
alterations in neuronal activity (such as cLTP) have little effect on the distribution
of NSG2 at synapses. This is in contrast to many endolysosomal vesicles, which
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NSG2 is thought to be present within. Thus, it remains unknown whether NSG2 +
vesicles represent a unique subtype of endolysosomal vesicles, or that only a
subset of endolysosomal vesicles are trafficked to particular synapses. In this latter
case we would predict that NSG2 would prohibit various types of endolysosomes
from

being

trafficked

in

an

activity-dependent

manner,

but

that

Rab4/5/Rab7/Lamp1 that lack NSG2 are preferentially able to be recruited to
synapses during heightened periods of synaptic activity. Future studies are
therefore required to distinguish between these hypotheses (see Discussion in
Chapter 5).
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Chapter 4: Does NSG2 confer unique functional properties to
synapses?
Introduction
A number of factors determine the number of AMPARs and consequently
the synaptic strength of a glutamatergic synapses. A number of these factors were
detailed previously in Chapter1 as well as discussed in many reviews (Malinow
and Malenka, 2002; Huganir and Nicoll, 2013). It is widely recognized that various
forms of synaptic plasticity, either Hebbian (LTP/LTD) or homeostatic scaling,
converge on these features of AMPARs (Turrigiano, 2008; Huganir and Nicoll,
2013). The number of AMPARs available to mediate synaptic transmission is
regulated by two major processes: 1) lateral diffusion and trapping (Borgdorff and
Choquet, 2002; Bats et al., 2007b; Ehlers et al., 2007), and 2) endo- and
exocytosis-mediated exchange between the plasma membrane and intracellular
stores (Petrini et al., 2009). An additional level of complexity is the alignment of
AMPARs with presynaptic active zones into nanocolumns (Tang et al., 2016b),
which is critically important for evoked activation of post-synaptic potentials
(Raghavachari and Lisman, 2004; Freche et al., 2011; Savtchenko and Rusakov,
2014). While lateral diffusion and trapping are largely responsible for the induction
of Hebbian plasticity, membrane trafficking is essential for maintenance (Lledo et
al., 1998; Lu et al., 2001; Kopec et al., 2007; Yang et al., 2008). Thus, while
mechanistically distinct, these two processes work in concert to permit persistent
alterations in synaptic efficacy via AMPAR surface expression.
Previous research has found that NSG1 is critically important for the
dynamic shuttling of AMPARs between intracellular compartments and the plasma
membrane during synaptic plasticity. For instance, expression of an anti-sense
construct or a dominant negative NSG1 peptide reduced AMPAR recycling to the
plasma membrane following NMDA stimulation (Alberi et al., 2005; Steiner et al.,
2005). This interference also blocked stable induction of LTP (Alberi et al., 2005).
Furthermore, NSG1 is expressed in recycling endosomes, and binds to AMPARs
and the scaffolding protein GRIP1. Interestingly, this binding appears to be activitydependent, where NMDA+TTX treatment enhanced GRIP1 binding, but NMDA
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alone significantly reduced binding (Steiner et al., 2005). In contrast, NSG2
overexpression significantly increases the amplitude of mEPSCs under basal
conditions (Chander et al., 2019). Critically however, while NSG2-mC
overexpression caused increases in mEPSC amplitude, it did not significantly alter
surface GluA1 intensity or density when a random sample of dendritic arbors were
examined (Chander et al., 2019).
Because NSG2 appears to be stably incorporated into a subset (~30%) of
synapses, we hypothesized that NSG2 may be critical for promoting AMPAR
surface expression at a minority of synapses that carry a disproportionate level of
activity in cultured neurons. In support of this idea, one study demonstrated that
homeostatic scaling in hippocampal cultures is not uniformly distributed across
synapses and cells, but primarily driven by changes in specific types of
hippocampal synapses (Lee et al., 2013). In this scenario, our previous
immunocytochemical analyses were not sensitive enough to detect changes in
surface AMPARs in NSG2-mC overexpressing neurons as we did not distinguish
between synapses that contained NSG2 and those that did not. If this is true,
targeted analyses of “NSG2 synapses” should reveal significant differences in
AMPAR surface expression. Furthermore, if NSG2-containing synapses do show
differences in surface AMPARs, alterations in NSG2 expression would be
expected to alter a neuron’s ability to undergo various forms of synaptic plasticity.
Lastly, if the unique expression pattern of NSG2 extends to other NSG family
members (e.g. NSG1), this would have significant implications for interpreting
previous data regarding their involvement in synaptic plasticity.

Materials and Methods
Neuronal cultures, Lentivirus Transduction, Immunocytochemistry and
Electrophysiology: Primary hippocampal neurons were cultured from P0-P1
mouse pups as previously described in Chapters 2 and 3. NSG2-mC and mCherry
lentiviral transduction of neurons were carried out as described previously in
Chapter 2. Immunocytochemistry and surface GluA stainings were carried out as

67

previously described in Chapter 2. Electrophysiological recordings of AMPA
mEPSC were carried out as previously described in Chapter 2.

Induction of Homeostatic plasticity: TTX based induction of homeostatic
plasticity was carried out essentially as described by Lee and colleagues (Lee et
al., 2013). Briefly, hippocampal neurons at DIV13-14 were treated with 1µM TTX
for 24h prior to recording and AMPA mEPSC were recorded on DIV14-15.

Image Analysis: Puncta size and Fluorescence intensity measures for surface
GluA1 and GluA2 were determined using Synpanal, a semi-automated software
for detection of neuronal punctae as previously described by Danielson and Lee
(Danielson and Lee, 2014).

Results
To determine whether NSG2-containing synapses display unique functional
properties we first examined the relative amount of AMPAR surface expression at
NSG2-containing synapses compared to those that lacked NSG2. We assessed
both the intensity and area of surface GluA2 punctae in DIV14 hippocampal
neurons. In cells overexpressing NSG2-mC we found that both fluorescence
intensity and surface area of GluA2 punctae were significantly greater in synapses
that contained NSG2-mC (Figure 14A-B; red, arrowhead) compared to those
lacking NSG2-mC (Figure 14A-B; arrow, Fluorescent Intensity, 388.06±28.83
(AUs) vs 660.16±45.62 (AUs); Puncta area, 0.179±0.007 (µm) vs 0.295±0.011
(µm); N=6 cells/group, 6-10 dendrite segments/group; 1290 NSG2 punctae; 2400
GluA2 punctae). However, we previously showed that overexpression of NSG2mC caused significant increases in mEPSC amplitude (Chander et al., 2019);
Chapter 2, Figure 6), which may be caused by increased levels of surface
AMPARs. Thus, we also tested whether surface AMPARs were also
disproportionately present at synapses that contained endogenous NSG2. Figure
14C-D shows that synapses that contained endogenous NSG2 (magenta,
arrowheads) displayed significantly greater area and fluorescence intensity of
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Figure 14: NSG2-containing synapses demonstrate elevated levels of surface AMPARs. (A)
Representative confocal images of DIV14 hippocampal neurons expressing NSG2-mCerry (red)
and stained for surface GluA2 (green); MAP2 is indicated in blue. (B) Pooled data showed
significantly increased surface area and fluorescence intensity of surface GluA2 in synapses that
colocalized with NSG2-mCerry (A, arrowhead) compared to regions that did not colocalize with
NSG2-mCherry (A, arrow). (C) Representative confocal images of DIV14 hippocampal neurons
stained for surface GluA2 (cyan) and endogenous NSG2 (magenta). Dashed lines indicate the
dendrite boundary using Alexa-fluor405 cell fill (omitted for clarity). (D) Pooled data showed
significantly increased surface area and fluorescence intensity of surface GluA2 in synapses that
colocalized with NSG2 (C, arrowheads) compared to NSG2-lacking synapses (C, arrows). For AD, N=6 cells/group, 6-10 dendrite segments/group. ***p<0.001.

GluA2 punctae (cyan) compared to those that did not (Figure 14C-D; arrow,
Fluorescence Intensity, 277.75±77.9 (AUs) vs 465.56±88.09 (AUs); Puncta Area,
0.112±0.009 (µm) vs 0.185±0.024 (µm); N=6 cells/group, 6-10 dendrite
segments/group; 2157 NSG2 punctae; 1753 GluA2 punctae). These results
suggest that NSG2 promotes increased surface AMPARs at a subset of synapses
rather than affecting all synapses equally, in line with timelapse imaging data
showing its relatively stable incorporation into a minority of PSDs (Chapter 3,
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Figure 10 and13). Furthermore, these data support the idea that NSG2 may be
incorporated into larger synapses, similar to MF-CA3 synapses (Chapter 3) that
display unique forms of plasticity. To test this we compared mEPSC amplitude in
neurons expressing mCherry with neurons expressing NSG2-mC and that were
either left untreated or were treated with TTX (1µM) for 24 hours to induce
upscaling (Lee et al., 2013). Interestingly, both TTX-treated cells and cells
overexpressing NSG2-mC displayed a significant increase in mEPSC amplitude
(Figure 15B, second, third bars, respectively). However, cells expressing NSG2mC did not show TTX-induced increases in mEPSC amplitude (Figure 15B, fourth
bar), suggesting that NSG2 overexpression prevented TTX-mediated scaling.
Together these data support the idea that NSG2 promotes alterations in PSD
function.

Figure 15: NSG2 modulates homeostatic synaptic plasticity. (A) Representative traces from
whole cell patch clamp recordings of DIV15 hippocampal neurons expressing either control
mCherry (upper trace) or NSG2-mCh (lower trace) either untreated or treated with 1µM TTX for
24hr. (B) Pooled data revealed a significant increase in the mean mEPSC amplitude upon TTX
treatment in the mCherry alone group. However, TTX treatment in the NSG2-mCh expressing
group did not promote basal increases in mEPSC amplitude (N=10-12/cells/group).

To determine whether NSG1 and NSG2 occupy overlapping or distinct
PSDs we quantified the percent that co-localized with PSD95 in DIV21
hippocampal neurons that were filled with Alexa-Fluor 405 (Figure 16A, AF405
signal omitted for clarity). Figure 16A, shows PSD95 punctae that co-localized with
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both proteins (arrowhead) as well as PSD95 that primarily colocalized with NSG2
(arrows). Pooled data demonstrate that approximately 17% of PSD95 punctae
colocalized with NSG1, ~33% colocalized with NSG2, and both proteins
colocalized with PSD95 in only ~5% of synapses (Figure 16B; n=9 cells, 5
dendrites/cell, and greater than 2300 punctae). Thus, the majority of synaptic
NSG1 and NSG2 proteins occupy non-overlapping PSD95+ domains. In addition,
to determine whether NSG1 could promote increased synaptic efficacy similar to
NSG2 under basal conditions, we overexpressed NSG1-mCh and assessed
mEPSC amplitude. Figure 16C and D, shows that mEPSC was unchanged
compared to cells expressing mCherry alone (Figure 16C; N=10-12 cells/group),
suggesting that NSG1 does not affect basal synaptic efficacy in the same manner
as NSG2 (Chander et al., 2019).

Figure 16: NSG1 and NSG2 show largely non-overlapping and discrete synaptic localization.
(A) Representative confocal images of DIV18 hippocampal neurons stained for NSG1 (green),
NSG2 (white), and PSD95 (red) in Alexa Fluor 405 filled cells (indicated by dashed line). Arrows
indicate NSG2/PSD95 colocalization and arrowhead indicates NSG1/NSG2/PSD95 colocalization.
(B) Pooled data show the proportion of PSD95 punctae that colocalize with individual or both
proteins (N=9 cells, 5 dendrites/cell, and greater than 2300 punctae). (C) Representative traces
from whole cell patch clamp recordings of hippocampal neurons expressing either control mCherry
(upper trace) or NSG1-mCh (lower trace). Pooled data indicates that NSG1 does not promote basal
increases in mEPSC amplitude (n=10-12/cells/group).

71

To begin to determine the molecular mechanisms for synapse-specific
properties we reasoned that particular domains were required for targeting NSG2
to particular synapses. We performed initial mutagenesis on NSG2 to delete the
majority of the N-terminus (ΔN-NSG2-mC; amino acids (AA) 2-60 deleted), the
transmembrane domain (NSG2-ΔTM-mC; AA 70-91 deleted), or the C-terminus
(mC-NSG2-ΔC; AA 101-171 deleted) (Figure 17A-B).

Figure 17: Mutant NSG2 proteins are deficient in their synaptic localization. (A) Diagram of
conserved (blue) and unique (green) domains, including predicted serine (S) and Threonine (T)
phosphorylation sites of NSG1/2. (B) Western blot of full length and mutant NSG2 proteins. (C)
Representative confocal images of DIV15 hippocampal neurons expressing NSG2-mC (red, top),
NSG2-C (red, middle) or N-NSG2 (red, bottom). Arrowheads indicate colocalization of NSG2
puncta with synaptic marker Homer1 (green). (D) Pooled data illustrate the percent of colocalized
NSG2 or NSG2 mutants with Homer1.

72

Figure 17B, shows western blot analysis, where all mutants demonstrate
appropriate changes in migration due to reduced molecular weight. Both the ΔN
and ΔC mutants expressed in a punctate pattern and were actively trafficked in
cells (not shown), suggesting they grossly mimic the full-length protein. However,
both mutants displayed significantly lower co-localization with Homer1 compared
with full-length NSG2-mC (Figure 17C and D; NSG2-mC: 35.8±4.1%; ΔN-NSG2mC: 8.5±1.8%; mCh-NSG2-ΔC: 5.8±1.1%, n=8 cells, 41 dendritic segments,
>2174 punctae; p<0.05 for each mutant compared to full length NSG2-mC).

Figure 18: NSG2 mutants fail to increase synaptic efficacy. (A) Representative traces from
whole cell patch clamp recordings of DIV15 hippocampal neurons expressing either control
mCherry, NSG2-mC or NSG2 mutants (as indicated). NSG2-mC expression significantly increased
mEPSC amplitude (A) and trended toward an increase in frequency (B). However, mEPSC
amplitude and frequency were not different from controls expressing mCherry alone in neurons
expressing the ΔN or ΔC mutants (N=11-12 cells/group, **p<0.02).

Interestingly, neither mutant was able to cause increases in mEPSC amplitude like
full-length NSG2-mC (Figure 18A), whereas none caused changes to mEPSC
frequency (Figure 18B; n=11-12 cells/group).
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Conclusion and Discussion
Here we sought to determine if NSG2 localizes to a subset of synapses and
alter their functional properties. We found that synapses that contained NSG2 had,
on average, larger sGluA2 clusters. This was true for both endogenous NSG2containing synapses and upon overexpression of NSG2-mCherry (Figure 14 and
Summary Figure 19). An interesting question arising from this finding is whether
NSG2 localization at these synapses causes the enlargement of these PSDs
resulting in larger AMPAR clusters, or whether NSG2 is selectively targeted to
these synapses. Future studies are needed to distinguish between the causeeffect relationship between the presence of NSG2 and heightened synaptic
efficacy.

Figure 19: Schematic showing that NSG2 localization at synapses correlates with larger
AMPAR clusters under basal conditions.

The fact that NSG2 localized to, and functionally affected, a subset of PSDs
led us to question whether this was true for other NSG family members. Previously,
it was shown by Yap and colleagues, that NSG1 and NSG2 show a ~60% overlap
in rat hippocampal neurons at DIV9. While we were able to recapitulate their
findings in mouse hippocampal neurons between DIV9-11 (data not shown),
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however these data say nothing about their localization at PSDs. NSG1/2
displayed differential localization at PSDs at DIV21, further emphasizing the
involvement of differential factors in specific synaptic recruitment of these proteins.
Additionally, it also suggests that these proteins may have either redundant
functions or work in conjunction early during development and become functionally
decoupled later in development. It was surprising to us however, that NSG1
overexpressing neuron did not cause differences in AMPA mEPSC properties
compared to control (Figure 16 and Summary Figure 20), especially because
NSG1 overexpression has previously been shown to modulate AMPAR recycling
(Steiner et al., 2002).
We were curious about how this differential distribution of NSG2 at
synapses would play out when we artificially induced homeostatic plasticity shown
to modulate a subset of large synapses proximal to the soma. In Chapter 3, we did
find some evidence that NSG2 may localize to large multiheaded spines proximal
to the soma of dye-filled neurons. Intriguingly, we found that NSG2 overexpressing
neurons were not able to upscale AMPA mEPSC amplitude to the same extent as
TTX treated control (Figure 15 and Summary Figure 21). Therefore, while TTX
treatment of neurons predictably increased AMPA mEPSC amplitude as did
NSG2-mC overexpression, TTX-dependent potentiation of AMPA current was
limited in NSG2 overexpressing cells. It is possible that NSG2 potentiates
synapses to a certain setpoint but does not allow further potentiation of the
complement of AMPARs within the PSD. It is clear that synapses could still
undergo greater levels of potentiation as TTX-treated cells show greater mean
amplitudes than those expressing NSG2. Thus, the presence of NSG2 essentially
clamps synapses at a high, but not maximal level of efficacy, and may abrogate
the ability of those synapses to undergo further upscaling. Future studies should
explore whether this effect of NSG2 affects other types of plasticity such at cLTP,
or homeostatic down-scaling.
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Figure 20: Schematic showing that overexpression of NSG1 does not lead to higher
amplitudes of AMPA mEPSCs unlike NSG2 indicative of a functional difference between
NSG1 and NSG2 containing synapses.
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Figure 21: Schematic showing that regular synapses undergo TTX dependent homeostatic
scaling up which is not able to undergo any further potentiation under NSG2 overexpression
conditions.
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Chapter 5: Conclusions and Discussion
Here we report the first functional characterization of a novel protein, NSG2.
NSG2 mRNA and protein was first discovered in rats (Saberan-Djoneidi et al.,
1995). NSG2 mRNA expression data is also available for zebrafish (Muthusamy
et al., 2015). Muthusamy and colleagues, previously carried out bioinformatics
based analysis of the NSG2 gene and suggested its emergence and evolutionary
conservation in vertebrates (Muthusamy et al., 2009). Interestingly, NSG2
expression has previously also been shown to be misregulated in certain types of
neurodegeneration (Yamanaka et al., 2014) and developmental disorders like Rett
Syndrome (Chahrour et al., 2008). We identified and verified NSG2 expression in
mouse and human neurons and showed its localization at a subset of synapses
(Chander et al., 2019).
We initially hypothesized that NSG2, the second member of the NSG family
(NSG1-3) of proteins would be critical for AMPA receptor exocytosis and surface
expression. This hypothesis stemmed from the simple notion that regulated
AMPAR trafficking requires endocytosis, recycling, and exocytosis. The first two
processes have been shown to be the domains of NSG3 and NSG1, respectively.
Thus, whether NSG family members were involved with AMPAR exocytosis
remained unknown. While much of our data support the idea that NSG2 does
promote AMPAR surface expression, it remains somewhat unclear as to the
complex interplay between NSG family members and AMPAR trafficking. This is
largely due to the fact that our data revealed unexpected localization and functional
properties of both NSG2 and NSG1, which may call into question previous
research.
To study NSG2, and the process of synaptogenesis in general, we initially
adopted the human pluripotent stem cell-derived neurons as a model system. One
of the primary motivation and advantage of using this model was, it represented
truly de novo synaptogenesis as opposed to a regenerative synaptogenic system
as in primary rodent neural cultures. Additionally, this system offers several
advantages – self renewing pluripotent stem cells allows for a potentially unlimited
capacity for expansion, ability to mimic and characterize some of the earliest
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events during functional neural development, closely follows the timeline of events
occurring during embryonic development. When cultured as a monolayer stem
cells display unique morphological landmarks during differentiation to neurons.
These include downregulation of pluripotency associated marker Oct4 and gain of
expression of the neuroepithelial marker Pax6 during the first week of
differentiation. This is followed by neural rosette like structures which resemble the
closure of the neural tube during embryonic development. The molecular
resemblance of this structure to a neural tube is authenticated by a positive
staining of the rosette lumen for N-cadherin. βIII-tubulin positive neurons are
derived at 3-4 weeks but are electrically inactive and stain poorly with pre-synaptic
markers such as Synapsin I. However, in the following week to ten days there is a
dramatic increase in the number of Synapsin I positive puncta accompanied by
gain of electrical activity. Incidentally, this also corresponds to the time during
embryonic development where we may witness twitching in the digits.
We rationalized that investigating the molecular changes occurring during
this critical window in neuronal differentiation where neurons go from being
immature to action potential firing functional neurons could reveal novel players
involved in functional neural development. Microarray gene expression analysis
revealed several novel candidate genes. NSG2 however stood out for several
reasons, but mainly because it was one among the top ten highly expressed genes
among all differentially expressed gene and the highest among novel functionally
uncharacterized genes. However, one limitation, which also suggests a possible
future direction for this study is that, we only profiled NSG2 in one human cell line.
While it would not be a leap to assume NSG2 is expressed in other cell lines, it
could have indicated how NSG2 is dysregulated in a disease iPSC line. While our
initial characterization of NSG2 cellular localization was carried out in parallel in
both human and mouse hippocampal neurons, the human neurons suffered from
inherent heterogeneity in terms of cell maturity and variability in synaptogenesis.
Therefore, we restricted our synaptic localization and functional studies to rodent
neurons.
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We demonstated that NSG2 alters AMPAR currents bidirectionally upon
knockout and overexpression. However, while the knockout of NSG2 altered
AMPA mEPSC frequency, NSG2 overexpression impacted the AMPA mEPSC
amplitude. Unfortunately, at the time of the publication of this thesis we were in the
process of procuring NSG2 KO animals and prospective studies could not come
to fruition in time to include those results here. Slice electrophysiology on
hippocampi from NSG2 KO mouse would have added more weight to our findings
about NSG2’s putative involvement in synapse formation/maintenance. While a
multitude of published studies have previously shown that in vitro findings translate
well in vivo, there are always exceptions. The results of these studies could have
better informed us about NSG2 localization at dendritic spines and regulation of
excitatory synaptic properties in a neural context which is closer to how it is found
in the intact brain.
Traditionally, the frequency is thought of as a correlate of presynaptic
function and more reflective of the number of synapses. In contrast the amplitude
is reflective of the strength of the synapse and determined by the number and
composition of AMPAR at the PSD. While the complex role of NSG2 is not
straightforward to deduce from these observations, we can begin to speculate the
possible mechanism of NSG2 by drawing some inference from our observation
that NSG2 knockout is accompanied by diminished PSD95 fluorescent intensity.
Additionally, we can take into consideration some recent studies that serve as a
precedent and help reconcile our findings regarding AMPA mEPSC frequency vs
amplitude upon NSG2 knockout and overexpression respectively.

The MAGUK hypothesis
NSG2 has been shown to have its highest expression during the period of
synapse formation and stabilization during early postnatal periods (SaberanDjoneidi et al., 1995; Semple et al., 2013; Barford et al., 2017).Alterations in NSG2
levels have similar effects on synaptic transmission as do changes to the MAGUK
family of scaffolding proteins. Interestingly, overexpression of either GluA1 or
GluA2 alone is not sufficient to produce increases in mEPSC amplitude or
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frequency (Hayashi et al., 2000; Sinnen et al., 2017; Watson et al., 2017).
However, disrupting AMPAR interactions with PSD95 results in increased AMPAR
surface diffusion and localization to extrasynaptic sites (Schnell et al., 2002; Bats
et al., 2007). Knockdown of MAGUKs causes a reduction in AMPAR mEPSC
frequency in dissociated hippocampal neurons by increasing the number of silent
synapses without affecting mEPSC amplitudes (Levy et al., 2015). In contrast,
PSD95 overexpression results in increases to AMPAR-mediated mEPSC
frequency and amplitude (El-Husseini et al., 2000). These results are similar to our
current findings for both NSG2 knockout and overexpression. Interestingly, both
the MAGUK knockout and overexpression effects on AMPAR current appear to be
developmentally regulated. Simultaneous RNAi-mediated knockdown of MAGUK’s
PSD95, PSD93 and SAP-102 altered AMPAR EPSCs only during early
development (P7-8) but not in adults (P35) (Levy and Nicoll, 2017). Similarly,
significant increases in AMPAR EPSCs were observed only when PSD95 was
overexpressed early during development as compared to adults (Levy and Nicoll,
2017). Finally, the NSG2 family member Calcyon has been previously shown to
associate with PSD95 (Ha et al., 2012), suggesting a possible conserved function
across family members. Unfortunately, our attempts to determine if PSD95 coimmunoprecipitates with NSG2 did not yield any conclusive results (Figure 22)
While the previous section suggests a uniformity of function across MAGUK
family members, functional differences in synaptic plasticity are associated with
differential expression of individual MAGUK family members (E.g. PSD93, PSD95,
and SAP102; (Elias et al., 2008; Sun and Turrigiano, 2011)). For instance, during
long-term homeostatic scaling, PSD95 accumulates in highly active PSDs while
SAP102 accumulates in PSDs that have reduced activity (Ehlers, 2003). Further,
PSD95 and SAP102 are assembled into physically distinct complexes (Elias et al.,
2008; Frank et al., 2016), which have been shown to have disparate roles in
shaping homeostatic scaling and Hebbian plasticity (Migaud et al., 1998; Elias et
al., 2006; Cuthbert et al., 2007; Carlisle et al., 2008), (Sun and Turrigiano, 2011).
Interestingly, the number, size and shape of PSD95 and SAP102 complexes within
dendritic spines has been shown to correlate with synaptic strength and is altered
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Figure 22: Representative Western blots showing inconclusive evidence for NSG2/PSD95
co-immunoprecipitation from HEK293T lysates coexpressing NSG2-mC and PSD95-GFP.
Top: Blot probed with anti-PSD95 and Bottom: Blot probed with NSG2. NSG2/PSD95 are not
detected in Lane 2 (HEK lysate – control), Lane 3 (Input + control) in each blot shows the respective
bands of correct sizes for PSD95 (top) and NSG2-mC (bottom). Non-specific IgG pull down gives
a non-specific smear precluding any useful conclusion (Lane 4; top and bottom). Lane 5 shows
IP:GFP and WB:PSD95 (top) and NSG2 (Bottom). It appears that PSD95 is immunoprecipitated,
but there is no co-immunoprecipitated NSG2-mC. Similarly, in Lane 6 IP: RFP, WB: NSG2 shows
NSG2-mC is immunoprecipitated, however it is inconclusive if PSD95 is co-immunoprecipitated.
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bidirectionally during plasticity (Ganeshina et al., 2004; Xu, 2011; Cane et al.,
2014). The functional diversity of PSDs based on PSD95/SAP102 expression is
thought to provide a mechanism for differential responses to synaptic inputs that
determine overall circuit properties (Grant, 2018). Lastly, a recent study that
mapped over 1 billion synapses using PSD95-GFP and SAP102-mKO2 transgenic
mice identify 37 unique types of synapses based on size, shape, intensity, and colocalization of PSD95 and SAP102 (Zhu et al., 2018). This study revealed a
remarkable, previously unknown diversity within the glutamatergic “synaptome”.
As mentioned, previous reports are highly suggestive of the fact that MAGUK
family members are differentially incorporated into PSDs within individual neurons
(Zhu et al., 2018). As MAGUKs are known to traffic in post-Golgi vesicles similar
to those NSG proteins occupy, it may be the case that individual NSG family
members aid in their delivery to, and function within PSDs. While most NSG1/2containing vesicles appear distinct from those that carry PSD95 based on transport
rate (Washbourne, 2015), it is worth examining in the future whether individual
MAGUKs occupy overlapping PSDs with NSG proteins.
Taken together, these findings suggest a developmental role for NSG2
where its primary function may be to support the trafficking of essential
components for synaptic stabilization and facilitate neurotransmission, rather than
on receptor trafficking per se.

The PSD nanodomain hypothesis
Several recent studies showing the presence of nanodomains within PSDs
may help explain how alterations in NSG2 levels differentially affect amplitude and
frequency of AMPAR-dependent mEPSCs. Sinnen et al. recently used
optogenetics to induce AMPAR interactions with PSD95 to recruit AMPAR into
postsynaptic densities. They found that forcing additional recruitment of AMPARs
to synapses was insufficient to increase AMPAR amplitude, but unexpectedly
resulted in increased mEPSC frequency. The authors concluded that AMPAR
recruitment at postsynaptic sites facilitated unsilencing of synapses by a novel
83

mechanism, whereby AMPARs are recruited to PSD95-containing nanodomains
at synapses that already contained surface AMPARs rather than to synapses
containing only surface NMDA receptors (Sinnen et al., 2017). Additional support
for this idea comes from super-resolution imaging studies that have enabled the
discovery of PSD95 subdomains within postsynaptic densities that cluster
AMPARs (MacGillavry et al., 2013; Nair et al., 2013; Tang et al., 2016).
A potential model for NSG2 function fits with the nanodomain hypothesis,
whereby NSG2 is responsible for helping to localize AMPARs into functional
PSD95+ nanodomains, but not overall AMPAR exocytosis. This model predicts that
NSG2 knockout should result in the loss of AMPARs localized to the PSD95 +
nanodomain causing reductions in mEPSC frequency as we observe in Figure 5.
Interestingly, NSG2 KO did not cause reductions in immunochemical labeling for
surface GluA1/2 subunits. Thus, NSG2 is critical for maintaining AMPAR-mediated
mEPSCs possibly through a localization-dependent mechanism, but may not be
required for bulk AMPAR exocytosis to the plasma membrane. In the context of
this model, it is somewhat difficult to reconcile a lack of effect on mEPSC amplitude
upon NSG2 knockout, where loss of NSG2 should result in reduced numbers of
AMPARs within functional nanodomains. However, it is possible that the effect of
chronic NSG2 KO as performed in our study results in complete elimination
AMPARs localized to nanodomains where NSG2 would have been recruited,
resulting in silencing. Because NSG2 is restricted to a subset of synapses (Figures
2 and 3), this could allow normal synaptic transmission at synapses where NSG2
is not normally present, resulting in reductions in frequency but not amplitude. The
nanodomain model makes different predictions for the effects of NSG2
overexpression, especially given the apparent restriction of NSG2 to a subset of
existing synapses. If NSG2-mC is recruited to both silent and functional (AMPARcontaining) synapses equally, we would expect increases in both mEPSC
amplitude and frequency. In contrast, if NSG2-mC is primarily recruited to existing
functional synapses, overexpression should result in greater recruitment of
AMPARs to PSD95 nanodomains that were not saturated with AMPARs, causing
increases in mEPSC amplitude but not frequency. While there was a trend toward
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increased frequency, the major effect of NSG2 overexpression was to increase
mEPSC amplitude (Figure 6). Thus, similar to the knockout findings, the lack of
effect on mEPSC frequency may be explained by a restriction of NSG2-mC
localization to functional synapses. Curiously, overexpressed NSG2-mC did
occupy a somewhat larger proportion of HOMER1+ synapses than its endogenous
counterpart (Figure 2), however this may not have been sufficient to significantly
increase mEPSC frequency due to unsilencing. Future studies are needed to
determine whether NSG2 is truly restricted to a subset of already functional
synapses and whether it is capable of shifting AMPAR localization between
nanodomains to determine the fidelity of this model.

Contrasting findings on the localization and orientation of NSG
proteins
Steiner et.al., had previously utilized a Triton-X100 based protein digestion
assay combined with western blotting to suggest that NSG1 has a Type-I
membrane orientation. Their results suggested that NSG1 did not localize to the
plasma membrane and the endosomal localized population of NSG1 has a lumenal
N-terminus and a cytosolic C-terminus (Steiner et al., 2002). In the same study,
they also found that NSG1 co-immunoprecipitated with the SNARE protein Stx13
which is involved in the endosomal recycling pathway and antisense mediated
knockdown of NSG1 altered surface recycling of Tf (Steiner et al., 2002). Similarly,
in hippocampal neurons, NSG1 was found colocalized with AMPAR subunit GluA2
after NMDA stimulated AMPAR endocytosis and antisense mediated knockdown
of NSG1 in hippocampal neurons led to retardation of GluA1 recycling to the cell
surface after NMDA stimulation. NSG1 was found strongly colocalized with
internalized Tf and Rab4+ vesicles in PC12 cells (Steiner et al., 2002). Fluorescent
Tf were allowed to be endocytosed in PC12 cells and assayed for their
colocalization with NSG1 at 3 min and 15 min. While there was little colocalization
at 3 min, a significant proportion of NSG1 localized with Tf after 15 min. The
author’s interpret this to mean that NSG1 associates with endosomal vesicles
beyond the initial endocytosis and fusion with early endosomes. Tf + compartments
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can be both EEs and REs and in order to distinguish if NSG1 colocalized with Tf +
EE or RE, they further treated the cells with either Brefeldin A (BFA) or Wortmanin.
BFA caused tubulation of Rab4+/Rab11+ late REs that contained Tf but hardly any
NSG1. However NSG1 largely colocalized with wortmanin sensitive enlarged Tf +
compartments that are Rab4+/Rab5+ EEs and intermediary REs (Steiner et al.,
2002). Additional immunolabeling experiments in PC12 cells revealed that NSG1
colocalized to a larger extent with Rab4+ REs, to a minor extent with Rab11+
vesicles and wortmanin sensitive endosomes but not with Rab5 +/EEA1+
compartments. Surprisingly, NSG1 did not colocalize with lysobisphosphatidic acid
(LBPA), a phopholipid enriched in LEs (Steiner et al., 2002). Unfortunately, the
colocalization data in this study were not quantified.
However, these findings are quite a contrast to Yap and colleagues (2017)
recent demonstration that a significant proportion of NSG1 and NSG2 was found
to overlap with Rab7+ LEs and traveling in a retrograde fashion which the authors
conclude were likely destined for degradation. Surprisingly, at the developmental
time chosen for the assay NSG1 and NSG2 puncta in dendrites showed
approximately 60% percent overlapping expression with the remaining 40% not
co-localized. Interestingly, smaller proportions of both NSG1 and NSG2 puncta
were found in EEA1+ EEs, Rab11+ REs, and Lamp1+ compartments (Yap et al.,
2017). Most intriguingly, this analysis accounted for nearly all NSG1+ punctae, but
only about 70% of NSG2+ punctae. Thus, it remains to be determined whether
there is an additional pool of unique, NSG2-containing vesicles. However, it must
be noted that this study focused only on an endocytosed population of vesicles.
This is critical because they revealed two properties of NSG1 and NSG2 that are
a complete contrast to earlier findings by Steiner et.al. The first is that NSG1/2 are
Type-II membrane proteins and have their N-terminus cytosolic and their Cterminus extracellular and the second that the proteins are present on the cell
surface. The surface population of NSG1 and NSG2 are detectable with live cell
staining under non-permeabilizing conditions with an antibody that targets a Cterminus epitope. Both proteins were shown to accumulate at the plasma
membrane when endocytosis is blocked by transfecting neurons with a Rab5-DN
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construct. While these findings are somewhat surprising, it is more in line with the
finding that NSG3 has previously been shown to be expressed at the cell surface
and alter its levels in response to calcium. Moreover, Shi et.al., have recently
shown that NSG3 associates with motor proteins to coordinates dynamic
microtubule dependent trafficking of LysoTracker+ late endosome and lysosome
related organelles within axons (Shi et al., 2018).

Lysosome mediated exocytosis hypothesis
Interestingly, recent evidence suggests that neuronal lysosomes are not
only responsible for degrading protein substrates near the soma and in axons, but
play a role in synaptic plasticity. The endo-lysosomal system is critical for
regulating forward trafficking, recycling, and degradation of integral membrane
proteins. It does so through a series of coordinated transitions through various
vesicles including EEs, LEs and REs, and finally lysosomes (Hu et al., 2015). Each
of these organelles is associated with the expression of specific Rab GTPases,
which are used as proxies for the identification of different vesicles. For instance,
RAB8 is generally involved in forward trafficking from the trans-Golgi network
toward the plasma membrane (Zhen and Stenmark, 2015). Following CME from
the membrane, proteins typically enter RAB5+ EEs and are then recycled back to
the plasma membrane via RAB4/RAB11+ REs, or targeted for degradation via
RAB7+ LEs which will ultimately fuse with LAMP1+ Lysosomes for final proteolytic
degradation (Hu et al., 2015).
Recent studies have however, started to elucidate the role of lysosomal
Ca2+ signaling in neurons, especially in postsynaptic Ca2+ release and plasticity.
Lysosomes are found throughout the dendritic arbour, including a fraction of
dendritic spines (Goo et al., 2017; Padamsey et al., 2017). Further, the localization
of these organelles is dynamic and activity-dependent, with glutamatergic
signaling recruiting lysosomes to the base of spine heads (Goo et al., 2017).
Padamsey and colleagues, reported that back propagating action potentials in
hippocampal pyramidal neurons elicited Ca2+ release from dendritic lysosomes.
Remarkably, this release triggered the fusion of the lysosome with the plasma
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membrane, resulting in the exocytosis of its luminal contents. Although many
lysosomal enzymes are inactive in the pH neutral environment of the extracellular
matrix (ECM), some such as Cathepsin B retain their activity (Mort et al., 1984;
Linebaugh et al., 1999) and are able to induce extracellular MMP-9 activity to allow
ECM remodeling. This process is essential for the maintenance of the functional
and structural changes associated with LTP (Wang et al., 2008; Wlodarczyk et al.,
2011). Consistent with this model, pharmacological inhibition of lysosomal fusion
or Cathepsin B activity, both of which impaired MMP9 activity, prevented long-term
maintenance of dendritic spine enlargements induced by Hebbian activity.
Moreover, chronic inhibition of lysosomal function or Ca2+ signaling, which is
implicated in lipid storage disorders, altered spine morphology and reduced spine
density (Goo et al., 2017; Padamsey et al., 2017). Of relevance to our study, it was
shown that inhibition of lysosome function with Leupeptin results in a significant
decrease in mEPSC frequency, without changing amplitude (Goo et al., 2017).
Since, the majority of NSG2 is found localized to RAB7+ LEs and LAMP1+
lysosomes (Yap et al., 2017). Our preliminary data (not shown) also suggests that
this constitutes a large synaptic fraction. Thus, future studies will focus on
understanding the nature of synaptic NSG2-containing vesicles is particularly
significant, as neither RAB7+ LEs nor LAMP1+ lysosomes have been shown to be
critical for maintaining AMPAR surface expression at PSDs (Hausser and Schlett,
2017).

Differential synaptic localization of NSG family proteins
Regardless of whether any of the proposed mechanisms above account for
differential trafficking of NSG proteins or their function within synapses, what is
clear is that both NSG1 and NSG2 specifically localized to subsets of glutamatergic
synapses at any given moment. This suggests a number of different possible roles
for NSG family members to affect synaptic function, one of the most significant
being the creation of synaptic diversity. Our observations related to the
disproportional changes in AMPA mEPSC observed in Chapter 2, and further
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described in Chapters 3 and 4, led us to hypothesize that NSG2 may be recruited
at specialized synapses harboring relatively higher levels of activity.
Synapse diversity at glutamatergic synapses has been recognized at the
laminar level for some time (Yogev and Shen, 2014), and the mechanisms for their
development and maintenance are beginning to be uncovered. A host of
transynaptic adhesion proteins have been shown to play critical roles in
synaptogenesis at excitatory and inhibitory synapses, including neurexins,
neuroligins, LRRTMs, SLITRKs, FLRTs, SALMs, and cadherins, to name a few
(de Wit and Ghosh, 2016). Many isoforms exist for each of these protein families,
and alterantive splicing creates potentially millions or billions of different binding
combinations between cis and trans-interacting partners in the synaptic cleft. For
the Neurexin-Neuroligin family, RNA-sequencing analysis found over 1,159
alternatively spliced isoforms of Nrxn1α and 1,120 for Nrxn3α alone (Treutlein et
al., 2014). It is difficult to imagine a scenario where this immense diverse protein
family produces largely redundant functions, leading neuroscientists to consider
whether there is an elaborate transynaptic code that promotes synapse specificity
and diversity (Sudhof, 2017).
Abundant examples exist for transynaptic specificity, but most appear to
encode

lamina-specific

connections

rather

than

truly

synapse-specific

connections. For instance, Netrin-G2 localizes specifically in the Schaffer collateral
axons and connects with the NGL-2 enriched CA1 dendritic spines in the stratum
radiatum (Nishimura-Akiyoshi et al., 2007). Interestingly DeNardo and colleagues
(2012), found that NGL2 knockdown reduced the synaptic density specifically only
in the CA1 proximal dendrites in the stratum radiatum and not in the distal dendrites
in the molecular layer (DeNardo et al., 2012). Anderson and colleagues, recently
described that LPHN2 is expressed in the dendritic spines of the CA1 hippocampal
neurons in the molecular layer, which is involved in forming synapses specifically
with the entorhinal cortex inputs. In a LPHN2 KO mouse model, reduced number
of spines were observed specifically in the CA1-entorhinal cortex synapses
whereas the dendritic spines in the stratum oriens and radiatum were not affected.
Interestingly, this region-specific ablation of LPHN2 did cause a homeostatic
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increase in the number of CA3-CA1 synapses in stratum radiatum (Anderson et
al., 2017). Furthermore, Um and colleagues (2016), found that the synaptic effects
of LRRTM2 KO specifically manifested in the dentate granule neurons and not
CA1 pyramidal neurons (Um et al., 2016). Similarly, LRRTM4 KO mouse showed
a lack of activity dependent trafficking of AMPAR only in the dentate granule
neurons and not in the CA1 neurons.
Aside from this work, the synaptic localization of NSG proteins is unknown.
However, based on functional properties and our preliminary data we can make
some hypotheses wither regard to their spatial segregation. NSG1 and NSG2 have
established roles in regulating activity-dependent (Alberi et al., 2005a; Steiner et
al., 2005a), and basal activity (Chander et al., 2019), respectively. While the
majority of hippocampal afferents terminate on PSDs that display similar types of
NMDA-dependent forms of postsynaptic plasticity, a major exception are the
Mossy fiber (MF) synapses of the dentate granule cells onto Hilar and CA3
pyramidal cells. The postsynaptic structure on the CA3 dendrite consists of an
elaborate multiheaded spine known as a thorny excrescence (TE) (Amaral and
Dent, 1981). Because of its size and position near the soma of CA3 neurons,
activation of single mossy fiber synapses can cause spiking in CA3 neurons.
Therefore, these are referred to as ‘‘detonator’’ synapses (Urban et al., 2001). This
pathway displays pronounced short-term facilitation and a presynaptic form of
LTP that is independent of NMDAR activation (Zalutsky and Nicoll, 1990; Nicoll
and Schmitz, 2005).
We hypothesize that NSG2 plays a predominant role in promoting robust
postsynaptic AMPAR surface expression under basal conditions, but perhaps
not during plasticity. Interestingly, we did find that many synaptic NSG2 punctae
appear to be located on proximal dendrites that grossly resemble MF synapses
(Figure 13A and B). Thus, the MF-CA3 synapse is a good candidate for the
incorporation of NSG2. Recently, some studies have identified a clear role of a
Cadherin type II isoform in synapse specificity. The development of the dentate
gyrus and CA3 mossy fiber synapses require Cadherin 9, which is enriched in this
region of the hippocampus. Predictably Cadherin 9 KD in vitro specifically reduced
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dentate gyrus – CA3 synapses while the other hippocampal synapses were
unaffected. KD of Cadherin 9 in vivo altered the morphology of TEs. The authors
suggest that Cadherin 9 present in the pre- and postsynaptic neurons specifically
facilitate synapse formation through hemophilic interactions (Williams et al., 2011).
Thus, future work should determine whether NSG2 works in conjunction with
Cadherin 9 to promote TE formation and function.
In order to ascertain if NSG2 confers unique properties to synapses,
another important future direction would be to perform glutamate uncaging at
individual synapses harboring NSG2 to compare their excitability with non-NSG2
synapses. One of the drawbacks of this experimental design is that we need to
deplete all the NSG2 in the neuron and rely on NSG2 overexpression to
discriminate between NSG2+ or NSG- synapse. However if NSG2 overexpression
significantly alters synaptic and/or AMPAR properties, it could mask the effect of
glutamate uncaging. One way to avoid this confound would be to use ‘rescue
expression’; this design would potentially avoid overexpression artifacts while
being able to visualize NSG proteins. To do so we could use overexpression of
NSG2-mCh in primary hippocampal cultures from NSG2 KO mice. As mentioned,
NSG2 is one of the most highly expressed transcripts and proteins in cultured
neurons (Floruta et al., 2017; Chander et al., 2019). Thus, we expect
overexpression driven by the Synapsin-1 (SYN1) promoter will produce levels
similar to endogenous proteins, but which could be tested via quantitative PCR
and Western blot.
Another means by which to address the “NSG2 synapse” identification
problem would be to identify the synaptic targeting domain(s). As mentioned, our
initial deletion of the entire N- or C-terminus significantly reduced synaptic
localization of NSG2. Future studies could perform targeted site-directed
mutagenesis of the N- and C-termini to determine whether small peptide
sequences promote synaptic targeting. Here we could use cultured neurons from
NSG2 KO animals that have been transduced with their respective full length and
mutant proteins and stained for surface AMPARs to determine what proportion of
PSDs are occupied by NSG mutants. If the minimal synaptic Targeting Domain(s)
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(TD) can be identified, we could attempt to tag those domains from each protein
to EGFP (EGFP-NSG2TD) in an attempt to target it to “NSG2 synapses” in primary
cultures. Occupation of the same proportion of synapses as full-length protein
would indicate sufficiency of the TD for synaptic targeting.
Lastly, one immediate future direction for this work would be to identify the
protein-protein interactome for NSG2. As mentioned, all NSG family members coimmunoprecipitate with AMPAR subunits, co-localize at synapses, and regulate
AMPA-mediated synaptic transmission. However, previous studies using mass
spectrometry to examine AMPAR interacting proteins have failed to identify NSG13 in rodents (Schwenk et al., 2009; Shanks et al., 2012; Schwenk et al., 2014) and
human (Bayes et al., 2011). This may be due to the fact that their interactions are
relatively transient during trafficking or that their interactions occur in insoluble
membranous fractions. Recently, an affinity purification approach that utilizes a
promiscuous E.coli biotinylation enzyme BirAR118G (BioID; (Roux et al., 2012))
has been developed to overcome these limitations. Furthermore, yeast displaybased directed evolution yielded a protein with faster kinetics (TurboID; (Branon et
al., 2018)) that has been used to identify synaptic protein complexes (Spence et
al., 2019). When TurboID is fused to a bait protein expressed in cells (Roux et al.,
2012), BirA-dependent covalent biotinylation occurs within 10–50 nm of the bait
protein and allows for efficient isolation and analysis of proximal proteins by
streptavidin-based affinity purification and mass spectrometry (Kim et al., 2014).
Compared to traditional affinity purification methods, BioID reactions occur in situ,
enabling the capture of protein complexes, including transient interactions and
insoluble proteins from subcellular compartments refractory to biochemical
isolation (Yao et al., 2015). Thus, proximity labeling could determine the proteins
associated specifically with the synaptic fraction of NSG2 when combined with the
proper controls for Golgi, cytoplasmic, and endosomal fractions of NSG2 that may
interact with overlapping and non-overlapping protein constituents.
Together, our data reveal for the first time, that NSG2 is an AMPAR-binding
protein that is required for normal synapse formation and/or maintenance. They
also reveal novel functional properties of NSG1 and NSG2, and more significantly,
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establish a novel type of synapse diversity based on the incorporation of various
NSG proteins.
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Appendix A: Differentiation paradigm and timeline of generation of hPSNs from
hPSCs.
Appendix B: Derivation of hPSNs from hPSCs is a valid model of synaptogenesis
and gives rise to known markers of functional presynaptic development.
Appendix C: Derivation of hPSNs from hPSCs is a valid model of synaptogenesis
and gives rise to known markers of functional postsynaptic development.
Appendix D: Derivation of hPSNs from hPSCs led to the identification of several
previously uncharacterized genes with putative roles in functional neural
maturation.
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Appendix A

Differentiation paradigm and timeline of generation of hPSNs from hPSCs
(Larsen et al., 2016):
Diagram illustrating the method and time course of neuronal differentiation used
in this study. Representative images show cellular morphology at various time
points during differentiation; image labeled “immature neurons” was taken from
neurons at day 30 and shows III-Tubulin, while the image labeled “functional
neurons” was taken at day 50 and shows III-Tubulin (red) and Synapsin-1
(green). Scale bars indicate 100 m.
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Appendix B
Presynaptic Markers

Derivation of hPSNs from hPSCs is a valid model of synaptogenesis and
gives rise to known markers of functional presynaptic development: Selected
genes shown for representation NRXN1, SNAP25, vGLUT1 and vGAT show
upregulation starting from <30 days and attain peak expression around 30-50 days
corresponding with functional maturation of hPSNs and synaptogenesis.
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Appendix C
Postsynaptic Markers

Derivation of hPSNs from hPSCs is a valid model of synaptogenesis and
gives rise to known markers of functional postsynaptic development:
Selected genes shown for representation GRIA1, GRIA2, GRIA2, GABRA2 and
GABRB2 show upregulation starting from <30 days and attain peak expression
around 30-50 days corresponding with functional maturation of hPSNs and
synaptogensis.
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Appendix D
Previously Uncharacterized

Derivation of hPSNs from hPSCs led to the identification of several
previously uncharacterized genes with putative roles in functional neural
maturation: NSG2 was one of the highest expressed novel uncharacterized gene,
and its gene expression profile closely paralleled that of GRIA1 and GRIA2
(Appendix C)
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